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ZUSAMMENFASSUNG 
Vor kurzem wurde gezeigt, dass Mikroorganismen des Magen-Darm-Trakts mit diesem 
kommunizieren und daher einen Einfluss auf den Stoffwechsel, das Immunsystem sowie auf 
das Verhalten des Wirtstiers nehmen. Eine steigende Anzahl an Anhaltspunkten zeigen, dass 
dieser Austausch auch in entgegengesetzter Richtung stattfinden kann und zwar durch das 
Wahrnehmen von Hormonen und anderer vom Wirt ausgeschiedenen chemischen 
Verbindungen durch die Mikroorganismen. Wir haben uns in dieser Arbeit mit einem der 
Schlüsselelemente der Wirts-Mikroben-Kommunikation befasst, in dem wir das Chemotaxis 
System untersucht haben, das externe Stimuli wahrnehmen kann. So haben wir die 
chemotaktische Antwort des symbiotischen Modelbakteriums Escherichia coli auf mehrere 
chemische Verbindungen, die sich im Magen-Darm-Trakt anreichern, untersucht: 
Katecholamine 3,4-Dihydroxyphenylalanin, Dopamin, Norepinephrin und 3,4-
Dihydroxymandelsäure; die Schilddrüsenhormone Serotonin und Melatonin; die 
Sexualhormone ß-Estradiol und Testosteron; Insulin; und die Polyamine Putrescin und 
Spermidin. Für Melatonin, Testosteron und Spermidin konnte gezeigt werden, dass sie 
chemotaktisch abweisend sind, wobei die stärkste abweisende Reaktion für Seperimidine 
beobachtet wurde und Epinephrin zeigte eine anziehende Wirkung. Für Dopamin, 
Norepinephrin, 3,4-Dihydroxymandelsäure und Insulin konnte eine zweiphasige Antwort 
beobachtet werden. 
Um den zugrundeliegenden Wahrnehmungsmechanismus für diese chemischen 
Verbindungen zu ermitteln haben wir die chemotaktischen Antworten von Stämmen 
untersucht, die Hybridrezeptoren mit der Kombination der Domänen der zwei am 
häufigsten vorkommenden Rezeptoren in E. coli, Tar und Tsr, exprimieren. Wir haben auch 
die Reaktion von mutierten Tar Rezeptoren untersucht, die eine umgekehrte 
chemotaktische Antwort aufweisen, was es uns erlaubt hat, die Rezeptorregionen zu 
identifizieren, welche auf die einzelnen chemischen Verbindungen reagieren. 
Während Hormone indirekt wahrgenommen werden, was hauptsächlich auf die 
Perturbation der Signaldomäne von Tar und Tsr zurückzuführen ist, schließt die Reaktion auf 
Spermidin den wenig vorhandenen Chemorezeptor Trg ein sowie das periplasmatische 
Bindeprotein PotD des Spermidinaufnahmesystems. Um schließlich die physiologische 
 
 
Bedeutung für das Wahrnehmen dieser chemischen Verbindungen für E. coli zu bestimmen, 
haben wir deren Auswirkungen auf das Wachstum untersucht. Der chemotaktische Effekt 
der untersuchten Verbindungen korreliert mit dem Einfluss auf das Wachstum und der 
Stabilität der Stoffe im Magen-Darm-Trakt, was auf die Spezifität des beobachteten 
Verhaltens hindeutet. Wir nehmen an, dass die abweisende Reaktion auf die chemischen 
Verbindungen, die eine Reaktion hervorrufen, es den Bakterien bei hohen Konzentrationen 
erlaubt, schadhafte Mengen von Hormonen und Polyaminen im Darm zu vermeiden.  
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SUMMARY 
Microorganisms of the gastrointestinal (GI) tract were recently shown to communicate and 
consequently influence the metabolism, immunity, and behavior of animal hosts. Increasing 
evidence suggest that communication can also occur in the opposite direction, with 
hormones and other host-secreted compounds being sensed by microorganisms. Here, we 
addressed one key aspect of the host-microbe communication by studying a very-well 
known system that senses external stimulus, the chemotaxis system. We analyzed the 
chemotactic response of a model commensal bacterium, Escherichia coli, to several 
compounds that accumulate in the GI tract, namely the catecholamines 3,4-
dihydroxyphenylalanine, dopamine, norepinephrine, epinephrine and 3,4-
dihydroxymandelic acid; the thyroid hormones serotonin and melatonin; the sex hormones 
β-estradiol and testosterone; insulin; and the polyamines putrescine and spermidine. 
Melatonin, testosterone and spermidine were shown to be chemorepellents, with the 
strongest repellent response observed for spermidine, and epinephrine showed an 
attractant response. Biphasic responses were observed to dopamine, norepinephrine, 3,4-
dihydroxymandelic acid and insulin.  
To determine the underlying sensing mechanism of these compounds, we investigated the 
chemotactic responses of strains expressing hybrid receptors that combine domains of each 
of the two most abundant receptors in E. coli, Tar and Tsr. We also studied the responses of 
mutated Tar receptors that show inverted chemotactic responses, which enable us to 
identify regions of receptors that sense individual compounds. While the hormones are 
sensed indirectly, mainly perturbing the signaling domain of Tar and Tsr, the response to 
spermidine involves the low-abundant chemoreceptor Trg and the periplasmic binding 
protein PotD, of the spermidine uptake system.  
Finally, to determine the physiological importance of these compounds to E. coli, we 
studied their effects on bacterial growth. The chemotactic effects of the tested compounds 
apparently correlate with their influence on growth and with their stability in the GI tract, 
pointing to the specificity of the observed behavior. We hypothesize that the repellent 
responses observed at high concentrations of chemoeffective compounds might enable 
bacteria to avoid harmful levels of hormones and polyamines in the gut.  
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INTRODUCTION 
1. Bacterial chemotaxis 
Bacteria have evolved systems that enables them to sense and move according to the 
different chemicals present in the environment. Motility provides an evolutionary 
advantage, as it enables bacteria to find suitable niches for survival and growth (1). Several 
types of motility have been reported in bacteria, including swimming, twitching and gliding 
(2). The most common way bacteria move is by swimming through their flagella, long helical 
filaments emerging from the cell surface. Each flagellum is anchored to the cell membrane 
driven by a motor and uses a transmembrane proton or sodium potential as energy source 
(3, 4).  
The enterobacterium Escherichia coli is propelled by three to eight flagella that are 
randomly distributed around the cell body. E. coli moves in a sequence of runs and tumbles 
referred to as random walk. When all the flagella rotate counterclockwise (CCW), a large 
bundle that uniformly rotates is formed propelling the cells in a forward direction, leading 
to a smooth swimming – called run. When at least one of the flagella changes its rotational 
direction from CCW to clockwise (CW), the bundle is disrupted, reorienting the direction of 
the cell which leads the cell to tumble (5-7). In the absence of any chemical gradient, 
bacteria motion is unbiased with runs lasting around 1-2 seconds and the tumbles around 
0.1 seconds (5), resulting in an efficient random walk that allows cells to explore their 
environment. However, in the presence of a chemical gradient (i.e. attractant or repellent 
chemicals, temperature), bacteria moves in a bias random walk with longer runs and 
reduced frequency of tumbling, allowing the cells to move up or down a gradient. This 
biased net movement of cells in a presence of a chemical gradient is termed chemotaxis (6, 
8, 9). The bacterial chemotaxis strategy relies on temporal comparisons for sensing changes 
of chemoeffector concentrations in the environment (10), rather than a spatial measure of 
the gradient along the cell body, as is the case for eukaryotic cells (5, 11). 
To detect and respond to their environment, chemotactic bacteria rely on three main 
molecular components: 
 
 
• Receptors: multiple clustered arrays of membrane spanning methyl accepting 
proteins (MCPs), mainly located at the polar ends of the cell 
• Motor: rotary molecular motors that drive helical flagella 
• Signaling: internal intracellular biochemical signaling cascade that connects the 
receptors to flagellar motors, and allows the cells to adapt to varying levels of 
external stimuli 
E. coli chemotaxis is extremely sensitive and robust. The chemotactic receptors can detect 
minute changes in the level of stimulation (12), close to the physical limit set by the noise of 
ligand binding (13). Receptors can also integrate multiple stimuli, enabling navigation of 
bacteria in mixed chemical gradients (14, 15). Moreover, intracellular signaling is highly 
robust against perturbations, such as variations in ambient ligand concentrations or in 
protein levels (16, 17), which allows cells to maintain efficient chemotaxis in varying 
environments. 
 
1.1. Receptors 
Receptors, or homodimers, form mixed clusters of trimers of dimers, where receptor 
trimers of dimers form the basic signaling units (18). E. coli has four ligand-binding 
chemotaxis receptors Tsr, Tar, Trg, and Tap. These are organized in three domains: a 
transmembrane sensory domain, a signal conversion domain, and a signaling domain that 
interacts with the kinase, CheA (Figure 1B). A fifth receptor, Aer, has a different topology 
with no periplasmic domain but an additional Per-Arnt-Sim domain (PAS) at its N-terminus. 
PAS domain typical employs a flavin adenine dinucleotide to sense redox changes along the 
membrane (19, 20). The transmembrane sensory domain is composed of an extracellular 
sensory domain and two transmembrane helices (TM1 and TM2). When a ligand binds to 
the pocket inside the sensory domain, it triggers conformational changes in the TM regions. 
This conformational signal is further transduced to the cytoplasmic part of the receptor by 
the signal conversion domain, consisting of a Histidine kinase adenylyl cyclase methyl-
accepting chemotaxis protein–phosphatase (HAMP) domain. The signaling domain contains 
Introduction 
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a methylation helix (MH) bundle, a flexible bundle, and a protein contact region that 
interacts with the kinase to regulate its activity (Figure 1B).  
E. coli receptors can be classified based on their binding substrates. The first class comprises 
the major, or high abundant, receptors Tar and Tsr, which bind to amino acids directly by 
the periplasmic domains. The second class comprises the minor, or low abundant, receptors 
Trg and Tap, which recognize sugars and dipeptides respectively via their periplasmic 
substrate-binding proteins (BPs) of ATP-binding cassette (ABC) transporters. Early 
chemotaxis studies already indicated that the differences between the two classes of 
receptors in the magnitude and range of responses derived from the two types of ligands 
(14, 21, 22), but the origin of those differences remained largely unclear. Apart from the 
different substrates, recognize by these receptors, major and minor receptors were 
believed also to differ in their copy numbers. The total number of minor receptors was 
previously estimated to be <1 000 copies per cell compared with ∼10 000 for major 
receptors (23), and this difference was frequently assumed to explain the apparently 
weaker responses mediated by minor receptors. Minor receptors also have truncated C-
terminus and lack the binding site for the adaptation enzymes, making them dependent on 
the proximity of neighboring major receptors for efficient adaptation (24). However, a more 
recent study found that the difference in copy number is smaller than previously calculated, 
constituting more than a quarter of the total receptor pool (25). It was proposed that a 
distinction must be made between directly and indirectly binding ligands, where indirect 
ligand binding has greater flexibility in the modulation of response sensitivity (25). 
Chemotactic response to mixtures of effectors showed that simultaneous stimulation by 
ligands of different receptors is additive, and that adaptation to ligands of one receptor 
does not interfere with signaling by other receptors (25). The signaling units formed by the 
mixed clusters can also amplify the signal by cooperativity (8, 26), leading to a higher 
sensitivity at low ligand concentrations and providing gain at higher ligand concentrations 
(27).  
 
 
 
1.1.1. Bacterial Hybrids Receptors 
Bacterial hybrid sensors are a powerful tool for characterizing specificity of novel ligands 
and for bacterial biosensors applications. The range of detectable ligands of a chemotaxis 
system can be expanded through the construction of hybrid receptors. Extracellular sensory 
domains from “donor” chemotaxis receptors can be conjugated with chemotaxis receptors 
or histidine kinases found in other species to form hybrid receptors. There are several 
examples of functional hybrid receptors from the same species, such as Tsr-Tar (28), Trg-Tsr 
(29), and Tap-Tar (30) in E. coli and McpB-McpC in Bacillus subtilis (31), as well as hybrids 
between PctA, PctB, and PctC from Pseudomonas aeruginosa (32, 33) and hybrid receptors 
from different species such as McpG from Pseudomonas putida and E. coli Tar (33). While 
there has been some success in engineering functional hybrids receptors, designing 
functional receptor hybrids remains a challenging task (34). One of the issues is the high 
sensitivity of chemotaxis receptors to small conformational perturbations, that can interfere 
with the signal transduction through the receptor (35).  
 
1.2. Motor 
The bacterial flagellar motor is a rotary machine that drives the helical flagellum. The 
purified flagellum consist of a long helical filament, a short hook, and a basal structure of 
four rings mounted on a rod (36-38), comprising of approximately 50 genes (39). The 
filament assembles from the end that is distal to the bacterium and forms a semi-rigid 
helix, the wavelength and handedness of which alters with changes in the direction of 
motor rotation. In the stator of the motor, protons move through the independent force-
generating units composed by the Mot complexes anchored to the peptidoglycan layer. 
These protons interact with the ring of ∼32 FliG proteins that are associated with the 
cytoplasmic component of the rotor, and this drives rotation. The exact mechanism by 
which the electrochemical gradient is coupled to mechanical rotation is unclear, but it 
probably involves electrostatic interactions between the stator and the rotor proteins 
(40). Phosphorylated CheY binds FliM proteins that are associated with the FliG rotor to 
generate a switch in the motor rotation direction (41). 
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1.3. Chemotaxis signaling pathway in Escherichia coli 
In E. coli, chemotaxis is regulated by the histidine kinase, CheA. CheA is anchored to the 
membrane receptors through an adaptor protein, CheW, which is associated and interacts 
with the large array of receptors, at their cytoplasmic end. Conformational changes of the 
receptors, triggered e.g. by the binding of chemoeffectors to the receptors and by changes 
in the level of receptor methylation modulate the autophosphorylation activity of CheA (42, 
43), in a cooperative manner. Attractant ligand binding decreases CheA activity while 
repellent binding enhances autophosphorylation. CheW is required for this regulation, 
although its exact function remains unclear. In the presence of a repellent, following the 
activation of CheA, the phosphoryl group is transferred to its cognate response regulator 
CheY, thereby activating it. Phosphorylated CheY (CheY-P) diffuses and binds to the flagellar 
motors to enhance the probability of a CW rotation, causing the cell to tumble. Sub-second 
dephosphorylation of CheY-P, which is ensured by the phosphatase CheZ (44), allows the 
CheY-P concentration in the cell to accurately follow and reflect the average 
autophosphorylation activity of the cell’s kinases. However, in the presence of an attractant, 
increased receptos stimulation results in CheA inactivation and suppression of tumbles, thus 
promoting continued swimming in this direction (44)(Figure 1A). 
As the cells swims in a gradient, receptors are also subjected to adaptation for it to reset 
and be receptive to changing conditions. Receptor adaptation is controlled by CheR and 
CheB, and catalyze methylation and demethylation respectively of four specific glutamate 
residues on the receptors (16, 45, 46). Methylation tunes the ability of the receptors to 
activate CheA, increased methylation activates CheA and decreases receptor sensitivity to 
attractants, resulting in sensory adaptation. Thus, enabling the cell to detect further 
changes in concentration, as it swims in chemical gradients. This resets the pathway activity 
upon an initial stimulation to the steady state, counteracting the effects of ligand binding - 
termed precise adaptation (11, 26, 47). Under most conditions, the signaling apparatus 
mediating bacterial chemotaxis exhibits perfect adaptation to chemoattractants, so that, 
the steady-state behavior of the system is independent of the concentration of a 
 
 
homogeneous distribution of the attractant. However, to higher concentrations of 
attractants the chemotaxis pathway shows increasingly imprecise adaptation, with a clear 
correlation between the time of adaptation to a step-like stimulus and the extent of 
imprecision. The imprecision results from a gradual saturation of receptor methylation sites 
at high levels of stimulation, which prevents full recovery of the pathway activity by 
disrupting the conditions required for precise adaptation (48). Because the process of 
receptor modification is slower than the initial response due to the enzymatic properties of 
CheR and CheB and their low copy numbers, receptor methylation provides a short-term 
memory of past conditions (47, 49, 50). In addition, CheB possesses an inhibitory domain, 
which is subject to negative feedback from CheA-dependent phosphorylation.  
In summary, the response process of the chemotaxis signaling pathway in E. coli occurs in 
the following way: 
1. The receptors sense canonically changes in the environment through binding of an 
extracellular ligand attractant to the sensory domain. 
2. Increase in attractant leads to the inactivation of CheA, leading to a reduction in the 
phosphorylation levels of intracellular proteins. 
3. The change or decrease in phosphorylated CheY levels change the motor rotational 
direction bias, thus leading to a rotational switch of the flagella from CW to CCW.  
4. The receptors adapt to sensory input in step 1 via methylation, by the CheR and 
CheB proteins that constitute the adaptation system.  
5. The final phase returns the system to its initial pre-stimulus state leaving it free to 
detect further changes in the extracellular ligand concentration. 
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Figure 1: (A) Chemotaxis signaling pathway in E. coli. Receptors form a sensory complex with the kinase CheA 
and the adaptor protein CheW. Binding of attractant or repellent to the sensory complex regulates the kinase 
CheA autophosphorylation activity. Phosphoryl groups from CheA can be transferred to the response 
regulators CheY, that controls flagellar rotation, and CheB, that controls sensory adaptation. CheY-P interacts 
with the motor switch complex, causing flagellar rotation to change from counterclockwise (CCW) to clockwise 
(CW), and the cell tumbles. CheY-P is rapidly dephosphorylated by the phosphatase CheZ, leading to a fast 
termination of the response. CheB-P acts on receptors by removing methyl-groups added by the 
methyltransferase CheR. (B) Schematic drawing of the Tar and Tsr receptors. Ligands bind to the periplasmic 
receptor domain. In the cytoplasm, a HAMP region, a methylation region, a flexible bundle region and a trimer 
contact region are indicated. Methylation sites are indicated by filled or empty circles. Figure adapted from 
(35). 
 
 
 
 
1.4. Stimulus spectrum of Escherichia coli chemotaxis 
Due to the exposure to a constantly changing environment, bacteria have evolved the 
ability to detect various stimuli. E. coli mainly recognizes nutrients and toxins that affect cell 
growth and survival. Examples of nutrients include L-amino acids, sugars and dipeptides. 
The most effective amino acid attractants are aspartate and serine, which elicit chemotactic 
pathway responses in E. coli at concentrations as low as 10-100 nM. Less effective 
attractants are threonine, asparagine, cysteine, glutamate, glycine, alanine and methionine 
(21, 51). E. coli is also attracted to sugars, such as D-glucose, maltose and N-acetyl-D-
glucosamine, which elicit chemotactic responses at concentrations of around 10 μM (14). 
Dipeptides can also be sensed by E. coli, such as Gly-L-Leu and L-Leu-L-Pro, with a threshold 
similar to sugars (52). In addition to an attractant response, E. coli also shows a repellent 
response to toxins, such as cobalt (Co2+), nickel (Ni2+) and some aromatic compounds (53). 
The taxis of E. coli cells in gradient of these chemicals is unidirectional, with cells always 
seeking the highest concentration of the attractants and lowest concentration of repellents.   
On the contrary, the taxis in gradients of many environmental factors, such as temperature 
(54), pH (28), osmolarity (55), and oxygen (19), is bidirectional. In this case, the cells swim 
either up or down the gradient depending on the ambient condition, and accumulate at an 
intermediate condition, rather than at the highest or lowest level. This intermediate is often 
thought to correspond to a physiological optimum for the cell. For example, E. coli is 
repelled to both very low and very high osmotic pressure, which enables it to accumulate at 
the more physiologically optimal intermediate osmolarity conditions (55-57). While 
unidirectional taxis of E. coli is comparatively well understood, mechanisms of bidirectional 
taxis in bacteria remain to be fully established. The bidirectional taxis behavior is likely to 
rely on counteracting repellent and attract responses of two receptors, where their strength 
are modulated by the ambient conditions. Examples of bidirectional taxis are the pH taxis, 
where Tar and Tsr oppose each other (53, 58-60), and temperature taxis, where highly 
methylated and low methylated receptors oppose each other (61-64). A recent study 
identified that low methylated receptors are thermophilic (heat seeking) and high 
methylated receptors cryophilic (cold seeking). In the absence of chemical attractants E. coli 
is thermophilic at all temperatures, on the other hand when high levels of chemical 
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attractants are present for both Tar and Tsr E. coli is cryophilic, and it accumulates at 
intermediate temperatures when only one of the receptors is adapted to high levels of its 
chemical ligands (61). 
Most of the attractants reported so far are nutrients that can be metabolized by E. coli, but 
metabolism-independent attractants were also found (21). E. coli also was shown to 
perform chemotaxis to self-secreted signals that can mediate collective behaviors, such as 
the autoinducer-2 dependent autoaggregation and biofilm formation (65, 66). Additionally, 
several previous studies have suggested that the animal pathogens Helicobacter pylori, 
Campylobacter jejuni and Salmonella enterica exhibit chemotaxis toward several 
compounds derived from the human gastric epithelium (67-71) and that such chemotaxis 
plays an important role in bacterial invasion as well as survival in the intestine (72-74). 
Moreover, both commensal E. coli K-12 and enterohemorrhagic E. coli (EHEC) were 
proposed to sense human hormones, namely norepinephrine (NE) as a chemoattractant 
(75-77). This response was suggested to require conversion of NE to 3,4-dihydroxymandelic 
acid (DHMA) by the monoamine oxidase TynA and the aromatic aldehyde dehydrogenase 
FeaB of E. coli, with DHMA then serving as the chemoattractant recognized by Tsr in a 
nanomolar concentration range (75, 77, 78). These results indicate that hormone taxis 
might be common among enteric bacteria and not limited to pathogens, but the scope of 
this behavior remains unclear.  
 
 
 
 
 
 
 
 
 
 
 
 
2. Microbial endocrinology 
The gastrointestinal (GI) tract is a highly innervated organ that possesses its own nervous 
system, the enteric nervous system (ENS). The ENS is in constant communication with the 
central nervous system (CNS), through various nerves such as the vagus nerve, which 
directly connects portions of the gut to the brain (Figure 2) (79). Due to this connection, the 
GI accumulates high concentration of hormones that are released into the duct system or 
lumen by the endocrine cells and neurons. These hormones have an important role in the 
immune response and in the containment of the commensal flora and elimination of 
pathogenic infections (80, 81).  
 
 
Figure 2: Brain-microbiome communication. Abbreviations: CNS – Central Nervous System, GI – 
gastrointestinal. 
 
The GI tract also hosts the most diverse microbial community of the human body. It is 
estimated that the gut microbiome comprises several thousand species of bacteria, 
archaea, eukarya, and viruses (82). In this highly complex ecosystem, the different species 
of microbes compete and cooperate with one another and with the host cells in order to 
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survive. Host-microbe interactions take place primarily along the mucosal surfaces. The 
gastrointestinal mucosa is the largest surface area within the body (approximately 40 m2), 
where only one layer of epithelia cells separates the contents of the lumen from the 
internal milieu. Environmental factors such as diet and antibiotics can affect the diversity of 
the microbiome. The gut microbiota plays important roles in host metabolism and 
immunity, by breaking down dietary components, educating the immune system and 
degrading toxins (83, 84). The gut microbiota may even influence human emotional states 
and diseases, such as stress related irritable bowel syndrome (IBS; (85)), and autism ((86, 
87), discussed later in section 2.1). These surprising findings show that the microbiota can 
modulate host behavior, raising the question of how these effects work functionally. In fact, 
the gut microbiome is now considered by some as a virtual organ in its own right (88), due 
to its interaction with the host through immune, neuroendocrine and neural pathways (89) 
and produce an array of bioactive molecules that directly interact with the endocrine, 
nervous and immune systems of their host (90-92). These pathways are components of the 
brain–gut–microbiota axis. 
Lyte and Ernst were the firsts to define a new field of research after observing that stress-
induced neuroendocrine hormones can influence bacterial growth (93). This field is named 
microbial endocrinology and assumes that through their long coexistence with animals and 
plants, microorganisms have evolved systems for sensing host-associated signals such as 
hormones. Detecting such signals enables the microbes to recognize suitable locations in 
the host and initiate expression of genes needed for host colonization (94-96). This interplay 
is bidirectional, since the microbiota has been shown to be both affected and to affect host 
hormones. It can also be direct, when the microbiota produce hormones (97-101), or 
indirect, when microbes may modulate the function of the adrenal cortex (which controls 
the anxiety and stress responses), or modulate inflammation and immune responses (85, 
96, 102). So far, two major groups of hormones have been identified as possible players in 
the bacterial effects on host behavior: the neurohormones, including serotonin and the 
catecholamines dopamine, epinephrine and norepinephrine and stress hormones, including 
cortisol, corticosterone, adrenocorticosterone and corticotropin.  
 
 
2.1. Brain disorders related to gut modulation 
Several studies found an association between gut–brain interactions and functional bowel 
disorders, chronic abdominal pain syndromes and even eating disorders. One of the most 
studied examples is the irritable bowel syndrome (IBS) that has been correlate with the 
microbiota composition (85). Additionally, a high comorbidity, i.e. the presence of one or 
more additional diseases or disorders co-occurring, was found between stress-related 
mental symptoms, as anxiety, and IBS (103), where over 50% of patients with IBS have 
comorbid depression or anxiety. In IBS patients, not only the quantity of commensal 
bacteria in the intestine is reduced, but also the diversity of the microbiota is altered (104-
107). In addition, preliminary studies have shown differences in the composition of the gut 
microbiota in patients with depression compared with healthy individuals (103, 108-110). 
Modulation of the gut–brain axis is increasingly being proposed as an appropriate target for 
the development of novel treatments for a wide variety of disorders that range from 
depression and anxiety to IBS, obesity and neurodevelopmental disorders (111, 112). 
 
2.2. Commensal Escherichia coli in the mammalian large intestine 
A wide variety of bacteria colonize the large intestines of humans and animals. The bacterial 
populations involved are relatively stable, consisting of hundreds of species that interact to 
achieve a relatively constant numerical balance (113). In human adults, the obligate 
anaerobes make up more than 99.9% of the cultivable bacteria (114). Prominent genera 
include Bacteroides, Bifidobacterium, Clostridium, Eubacterium, Fusobacterium, 
Lactobacillus, Peptococcus, Peptostreptococcus, and Veillonella (115). Escherichia coli is the 
predominant facultative anaerobe in the gastrointestinal tracts of mammals (116). How E. 
coli colonizes the mammalian large intestine is not well understood, however increasing 
evidence suggests that the commensal E. coli niche in the GI tract is the mucus layer of the 
large intestine (117). Fluorescence in situ hybridization of mouse intestinal showed that E. 
coli BJ4, a rat commensal isolate, is dispersed in the mucus layer but is not associated with 
the epithelium (118). The same appears to be true for the human commensal strain, E. coli 
MG1655 (119). In vitro, rapid growth in intestinal mucus, but not in luminal contents, 
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advocates that E. coli and Salmonella enterica serovar Typhimurium grow on nutrients 
acquired from mucus (120, 121). Thus, the ability of E. coli to grow and survive in mucus 
appears to be critical for intestinal colonization. If so, commensal strains of E. coli have to 
bind to gut receptors to avoid rapid washout (122).  
 
2.3. Hormones 
In the mucus layer, E. coli is exposed to numerous host signals, such as hormones. In the 
next chapters we will discussed some gut signals to which E. coli might be exposed.  
Hormones are chemical molecules produced by the endocrine glands and then transported 
by the circulatory system to target distant organs to regulate physiology and behavior. The 
endocrine system regulates our heart rate, metabolism, appetite, mood, sexual function, 
reproduction, growth, development and sleep cycles (123). Hormones have diverse 
chemical structures, mainly of three classes: eicosanoids, steroids, and amino acid/protein 
derivatives. Hormones affect distant cells by binding to specific receptor proteins in the 
target cell, resulting in a change in cell function. When a hormone binds to its receptor, it 
activates a signal transduction pathway that typically activates gene transcription and 
increases expression of target proteins.  
Hormone secretion occurs in response to specific biochemical signals from a wide range of 
regulatory systems. Upon secretion, certain hormones, including protein hormones and 
catecholamines, are readily transported through the circulatory system, since they are 
water-soluble. Other hormones, including steroid and thyroid hormones, are lipid-soluble, 
so in order to spread, these hormones must bond to carrier plasma glycoproteins (e.g., 
thyroxine-binding globulin) to form ligand-protein complexes. Some hormones are 
completely active when released into the bloodstream (as is the case for insulin and growth 
hormones), while others are prohormones that must be activated in specific cells through a 
series of activation steps that are usually highly regulated. The endocrine system secretes 
hormones directly into the bloodstream typically into fenestrated capillaries, whereas the 
exocrine system secretes its hormones indirectly using ducts.  
 
 
Neurohormones are secreted from neuroendocrine cells in response to a neuronal input. 
Although they are secreted into the blood for a systemic effect, they can also act as 
neurotransmitters. Neurotransmitters are endogenous chemicals enabling the transmission 
of signals across the chemical synapses, such as a neuromuscular junction, from one neuron 
to another target neuron, muscle cell, or gland cell (124). Neurotransmitters are released 
from synaptic vesicles in synapses into the synaptic cleft, where they are received by 
neurotransmitter receptors on the target cells. Many neurotransmitters are synthesized 
from simple and abundant precursors such as amino acids, which are readily available from 
the diet and only require a small number of biosynthetic steps for conversion (125).  
In this section, we will discuss in more detail the class of hormones studied throughout this 
work: catecholamines, thyroid hormones, sex hormones and the peptide hormone insulin. 
 
2.3.1. Catecholamines 
Structurally, the catecholamine family is a group of widely acting effector compounds 
derived from tyrosine and other dietary amino acid sources. They chemically comprise a 
benzene ring with two adjacent hydroxyl groups and an opposing amine side chain (126). 
The synthesis pathway for catecholamines begins with dietary L-tyrosine, which is ingested 
within the food or synthesized in the liver. L-tyrosine is taken up from blood and 
concentrated within the brain and other catecholamine-synthesizing tissues by a 
transporter for neutral amino acids. L-tyrosine is converted to 3,4-dihydroxyphenylalanine 
(L-DOPA). L-DOPA is enzymatically converted into dopamine, norepinephrine (NE) and 
finally epinephrine (or adrenaline) (Figure 3). Besides playing endocrinological roles such as 
controlling cognitive abilities, mood and gut motility, dopamine, NE and epinephrine also 
directly function as neurotransmitters and are used in both the CNS and peripheral nervous 
systems. Receptors for NE and dopamine, called noradrenergic and dopaminergic receptors, 
containing nerve terminals are widely distributed within the mammalian body, including the 
GI tract where they are components of the ENS (79, 125, 126). Dopamine is synthesized in 
non-sympathetic enteric neurons located within the intestinal wall (79, 125-127) and it is 
responsible for maintaining a sufficiently high level of locomotive activity and helping the 
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performance of complex voluntary movements while suppressing involuntary ones and 
maintaining and active wakeful state. This hormone has been found in large amounts within 
the GI, with high levels occurring in organs, such as the stomach, and in extracellular fluids, 
such as gastric juice (127, 128). The hormones epinephrine and norepinephrine are released 
from the adrenal medulla throughout the body, including the intestinal tract, being part of 
the fight-or-flight response. Within the gut NE is released from storage within sympathetic 
nerve fibers within the pre-vertebral ganglia innervating the gut mucosa, and it has been 
shown that up to half of the NE made within the mammalian body is synthesized and 
utilized within the ENS (126). However, neurons containing phenylethanolamine N-
methyltransferase, the enzyme required for the synthesis of epinephrine from NE, are not 
expressed in the intestinal mucosa (79), making it unlikely that adrenaline would normally 
be present at any significant level. Norepinephrine activates the brain, increases locomotive 
activity, decreases the anxiety level, and promotes human/animal aggressive behavior. In 
addition to neuron cells, immune cells appear to be capable of synthesizing, releasing and 
degrading catecholamines. There is an abundance of immunocytes throughout the 
intestinal lamina propria, and these cells, may represent an alternate non-neural source of 
dopamine and NE in the intestine wall (128). NE can be reduced to 3,4-
dihydroxyphenlygycolaldenyde, by monoamine oxidase, that can be oxidized in a less 
favored reaction into DHMA and its real concentration in the gut is unknown.  
 
 
 
Figure 3: Scheme of the catecholamine biosynthetic pathway in humans. 
 
Owing to the abundance of catecholamines hormones in the GI tract, most microbial 
endocrinology studies have focused on the interaction of gut bacteria with the 
catecholamines epinephrine, norepinephrine (NE) and dopamine. The first studies focused 
on the link between stress and the risk of developing an infection and found a correlation 
between the release of stress hormones with a reduction in the immune function (96, 110, 
129). In bacteria, catecholamines were also reported to alter growth, motility, biofilm 
formation and/or virulence (94-96, 130). In more detail, Helicobacter pylori has been shown 
to change L-DOPA levels in the gut correlating with an increase in the risk of developing 
Parkinson disease (131). It has also been suggested that NE increases the growth and 
virulence of enteric bacteria (93, 132), through signaling via adrenergic receptors located 
either on intestinal epithelial cells or in the bacteria (133). In enterohemorrhagic E. coli 
(EHEC), adrenaline and NE signaling affects bacterial virulence and motility (134).  
In terms of determining the in vivo levels of catecholamines, there are some considerable 
technical challenges. For the gut, variations in food catecholamine content, rapid enzymatic 
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turnover of gut catecholamines, and the adsorbent nature of fecal matter have all posed 
technical barriers to a definitive statement on active catecholamine levels (135, 136).  
 
2.3.2. Thyroid hormones 
Thyroid hormones are commonly derived from tyrosine and tryptophan amino acids. They 
are produced by the thyroid gland and are primarily responsible for the regulation of the 
metabolism. The L-tryptophan pathway is in charge of the synthesis of two important 
hormones: serotonin and melatonin (Figure 4). 
Serotonin (5-hydroxytryptamine (5-HT)) is one of the main neurotransmitters in the brain. It 
is found in the central nervous system of mammals, although over 90% of the mammalian 
host’s serotonin is found in the intestine (137). Intestinal serotonin secretion is affected by 
diet, and regulates intestinal movement, mood, appetite, sleep and cognitive functions. 
Serotonin has been implicated in GI pathologies such as IBS and Crohn’s disease (138). The 
first direct effect of the microbiome on serotonin was demonstrated in germ-free (GF) mice, 
which had lower plasma serotonin levels than conventional mice (139).  
Melatonin (5-methoxy-N-acetyltryptamine) is found in animals, plants, fungi and 
photosynthetic bacteria (140). In mammals, it senses the photoperiod and is involved in the 
entrainment (synchronization) of the circadian rhythms of physiological functions including 
sleep timing, blood pressure regulation, seasonal reproduction and many others, its 
secretion is regulated by NE. Especially during the daytime, the GI tract releases significant 
concentrations of melatonin, which influences the regeneration and function of epithelium, 
enhancing the immune system of the gut, and reducing the tone of gastrointestinal muscles. 
The release of gastrointestinal melatonin seems to be related to the periodicity of food 
intake (141-143). Recent papers also postulated that melatonin may also alter the 
microbiome composition (144), by for example increasing the proliferation of Enterobacter 
aerogenes (145). 
 
 
 
Figure 4: Scheme of the biosynthetic pathway of melatonin in the pineal gland of humans. 
 
2.3.3. Sex hormones 
Sex hormones, or steroid hormones, include estrogens, androgens, and progestogens 
naturally produced in the gonads by adrenal glands or by the conversion from other 
steroids. They influence the development of genital organs (estrogen and androgen), 
maintenance of pregnancy (progestogens), ovulation (estrogens), spermatogenesis 
(androgens), and sexual differentiation of the brain (estrogen and androgen). The actions of 
these hormones are mediated through the estrogen receptor, androgen receptor, and 
progesterone receptor (146). The two main classes of sex steroids are androgens and 
estrogens, of which the most important human derivatives are testosterone and estradiol, 
respectively. The third class, progestogens, includes progesterone the most important and 
only naturally occurring human progestogen (Figure 5).  
Examples of bacteria affected by sex hormones have been reported since the 1980s. For 
instance, Prevotella intermedius takes up estradiol and progesterone, which enhance its 
growth (147). Clostridium scindens was reported to convert glucocorticoids to androgens 
(148). Sex hormones were also involved in the development of obesity and metabolic 
disorders, however the interrelationship between the balance of sex hormones and 
metabolism is complex, and the underlying mechanisms are still unclear (149). 
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Figure 5: Scheme of the biosynthetic pathway of sex hormones classes: progestogens, estrogens and 
androgens of humans. 
 
 
2.3.4. Insulin 
Insulin is a peptide hormone produced by beta cells of the pancreatic islets, it regulates the 
metabolism of carbohydrates, fats and proteins by promoting the absorption of glucose 
from the blood into liver, fat and skeletal muscle cells. Circulating insulin affects the 
synthesis of proteins in a wide variety of tissues. Insulin is composed of two peptide chains 
referred to as the A-chain and B-chain. A- and B-chain are linked together by two disulfide 
bonds, and an additional disulfide is formed within the A-chain. In most species, the A-chain 
consists of 21 amino acids and the B chain of 30 amino acids (Figure 6). 
The first described link between insulin and bacteria was in 1981 by Le Roith et al. that 
discovered that Escherichia coli K12 possesses an insulin-like molecule with strikingly 
similar, if not identical, properties to mammalian insulin (92). One decade later human 
insulin was described to inhibit the growth of Burkholderia pseudomallei, which makes it 
unsurprising that this species is a major pathogen of type 1 diabetics (150). Since then, 
other connections have been found between insulin and the microbiome. Significant 
variations in microbiome composition have been observed in diabetes patients compared to 
healthy controls. The abundance of certain bacterial species has been either positively or 
negatively correlated with insulin levels (151, 152)  
 
 
Figure 6: Scheme of human insulin. Chain A is represented with black and chain B is represented with grey. 
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2.4. Polyamines 
Polyamines are signaling compounds that do not fulfil the true definition of hormones, but 
have similar functions. They are widely distributed from prokaryotic (153) to eukaryotic cells 
(154) and are found at especially high concentration in proliferating cells, such as cancer 
cells (155). Polyamines are aliphatic amines with two or more amino groups in their 
chemical structure. The main polyamines are putrescine, spermidine and spermine and they 
are synthesized from the amino acid ornithine (Figure 7). The first step in the pathway is the 
production of ornithine from arginine by the mitochondrial enzyme arginase. Three main 
sources for polyamines exist in organisms: food intake, cellular synthesis and microbial 
synthesis in the gut, where ingested food is the major one (156). Shortly after a meal, 
polyamine concentrations in the duodenal and jejunal lumen reach almost millimolar levels, 
but 120 min after the meal luminal polyamine content returns to fasting level in the order 
of tens to hundreds of micromolar concentrations (140). Polyamines play an important role 
in cell proliferation and differentiation (153), because they stabilize nucleic acid structure 
(157) and promote protein synthesis (158). 
  
Figure 7: Polyamine synthesis pathway in humans. 
 
Polyamines were described to protect bacteria against toxic effects of oxygen, superoxide, 
and hydrogen peroxide (159). Polyamines have been also implicated in the control of 
biofilm formation in several human pathogens (160). The bacterial polyamine uptake, 
 
 
synthesis and degradation are coordinated to stringently regulate intracellular polyamine 
levels. In E. coli, polyamine uptake is energy dependent, and the putrescine transport 
system is different from the spermidine and spermine transport systems (161). Both are 
ABC (ATP binding cassettes) transporters consisting of a substrate binding protein in the 
periplasm, two channel-forming transmembrane proteins, and a membrane-associated 
ATPase that is involved in energy supply. The putrescine uptake system is composed by 
PotF, PotG, PotH and PotI proteins and the spermidine uptake system by PotA, PotB, PotC 
and PotD proteins. The uptake system consists of a periplasmic protein (PotD and PotF), a 
membrane associated protein with a nucleotide-binding site (PotA and PotG), and two 
membrane proteins (PotB/PotC and PotH/PotI) with six membrane-spanning segments 
linked by hydrophilic segments of variable length (Figure 8) (162, 163). 
 
 
Figure 8: Schematics of preferential transport systems for spermidine (SS) and putrescine (PS). Spermidine is 
represented by red diamonds, putrescine is represented by blue diamonds that bind to the periplasmic 
proteins (PotD and PotF), which pass the signal to the membrane associated proteins (PotB/PotC and 
PotH/PotI) attached to the ATPase proteins (PotA and PotG). 
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3. Iron uptake systems in Escherichia coli 
Several studies demonstrated that gram-negative and gram-positive bacteria exhibit 
increased growth following supplementation of culture medium with dopamine and other 
catecholamines (132, 164). These effects do not appear to be mediated by a mammalian-
type adrenergic receptor, as the growth enhancement could not be blocked by standard 
pharmacological blocker (93). Since catechol rings are known siderophores in bacteria, it 
has been proposed that these effects are due to siderophore activity of the catecholamines, 
that enhance growth by improving iron uptake in growth-limiting media (165). 
Bacteria use a variety of iron sources, the most common is Fe3+. Since Fe3+ is insoluble in 
water, solubilization is required before for its uptake into the cell. Siderophores are low-
molecular-weight compounds that bind Fe3+ tightly and specifically (166). Siderophores are 
synthesized by microorganisms and secreted into the surroundings. The Fe3+-siderophores 
complexes are actively transported into the cells. Once in the cytoplasm, iron is released 
usually by reduction to Fe2+ and the siderophores degraded, modified and secreted for the 
next cycle of Fe3+ transport. Iron is transported into Escherichia coli by a number of 
chelating compounds, as citrate, ferrichrome, enterobactin, aerobactin, yersiniabactin, and 
heme through ABC transport systems. Transport across the outer membrane requires 
energy generated by the proton motive force of the cytoplasmic membrane and 
transmitted to the outer membrane via the TonB-ExbB-ExbD proteins (167). Binding of 
substrates induces structural changes in the transport proteins, but it does not open the 
channel. It is thought that the channel is opened by energy input from the cytoplasmic 
membrane. Although a basic understanding of how the transport proteins could function 
were obtained from crystal structures studies of three outer membrane proteins of E. coli 
and from many genetic and biochemical experiments, numerous fundamental questions still 
remain open. Transcription of the transport protein genes is regulated by the Fur protein, 
which when loaded with ferrous iron functions as a repressor. Fur also positively regulates 
genes of iron-containing proteins by repressing synthesis of an anti-sense RNA. Regulation 
of ferric citrate transport genes via a transmembrane device has become the paradigm of 
the regulation of a variety of systems, including the hypersensitivity response of plants to 
 
 
bacterial infections (168, 169). Eight outer membrane proteins - FepA, Fiu, Cir, FhuA, FhuF, 
FhuE, IutA and FecA - transporting ferric siderophores have been determined (Figure 9).  
The FecA protein transports ferric citrate across the outer membrane and regulates the 
transcription of the ferric citrate transport (170). FhuA is a multifunctional protein that 
transports ferrichrome (171). The FepA protein transports ferric-enterobactin across the 
outer membrane and serves as receptor for colicins B and D. The IutA protein transports 
ferric-aerobactin. Aerobactin is a siderophore synthesized by certain naturally isolated 
strains of E. coli (172). Further transport of ferric-aerobactin across the cytoplasmic 
membrane is mediated by the FhuBCD transport system of ferrichrome and other ferric-
hydroxamate siderophores (173). The FhuE protein functions as the receptor for ferric 
coprogen and ferric-rhodotorulic acid (174). FhuF mediates the transport to ferrioaximine B 
(175). Lastly, Cir and Fiu proteins were described to transport dihydroxybenzoyl serine (176, 
177). 
E. coli also grows under anoxic conditions, which predominate in the gut. In a reducing 
environment, iron is present as Fe2+, which has a much higher solubility than Fe3+. A 
transport system for Fe2+ has been characterized genetically (178). Three genes, feoABC, are 
required for Fe2+ uptake, where FeoB seems to be the transport protein. The function of the 
feoA gene and feoC gene are not known. Fe2+ can also be taken up by the Mg2+ transport 
system and may accumulate to toxic concentrations (95). A Mn2+ transport system encoded 
by the mntH gene also transports Fe2+ with low affinity. mntH is repressed by Fe2+-Fur and 
Mn2+-MntR, a specific repressor of mntH transcription (179).  
 
Introduction 
  
 
Page | 39  
  
 
Figure 9: Scheme of the iron transport proteins in E. coli. The eight outer membrane proteins are highlighted 
in different colors – FepA, Fiu, Cir, FhuA, FhuF, FhuE, IutA and FecA, as well as the transport regulator Fur.  
 
 
AIMS 
In the last decade, the perspective about microbial endocrinology has drastically changed 
with the discovery of a broader range of hormones that can affect bacteria physiologically 
along with the reports of bacteria that produce mammalian-like hormones. The evolution of 
the bacteria in the human gut suggests that it could sense and respond to the hormones in 
the GI tract. Since bacteria have a well-known system that sense external stimuli, the 
chemotaxis system, the main goal of this work was to evaluate if E. coli can respond 
chemotactically to different concentrations of compounds present in the GI tract, namely 
catecholamines, thyroid hormones, sex hormones, insulin and polyamines. To investigate 
the mechanism of these responses, we also aimed to determine their respective effects on 
strains expressing individual receptors, as well as various Tar constructs and hybrid 
receptors. Finally, we tested the effects of these compounds on bacterial growth in order to 
unravel the physiological importance of these hormones to bacteria. 
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MATERIAL AND METHODS 
1. Chemicals and consumables 
Main chemicals and consumables used in this work are listed in Table 1. 
Table 1: List of chemicals 
Chemicals Company 
Agar bacteriology Applichem 
Agarose ultra-pure Difco 
Albumin Fraktion V Roth 
Ammonium Sulfate ((NH4)2SO4) Sigma 
Ammonium Nitrate (NH4NO3) Roth 
Ampicillin Applichem 
Arabinose Roth 
Bacto yeast extract BD Biosciences 
Bacto tryptone BD Biosciences 
Chloramphenicol Applichem 
D-glucose Applichem 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
DL-3,4-Dihydroxymandelic acid (DHMA) Sigma-Aldrich 
Dopamine hydrochloride Sigma-Aldrich 
D-ribose-5-phosphate Roth 
EDTA Merck 
(−)-Epinephrine Sigma-Aldrich 
β-Estradiol Sigma-Aldrich 
Glacial acetic acid Roth 
Glycerol 99.5% Gerbu 
Isopropyl-β-D-thiogalactoside (IPTG) Roth 
Insulin Applichem 
Kanamycin sulphate Sigma-Aldrich 
Lactic acid Sigma-Aldrich 
L-Arabinose Applichem 
L-Aspartate Sigma-Aldrich 
L-Dopa-(phenyl-d3) (L-3,4-dihydroxyphenylalanine) Sigma-Aldrich 
L-Leucine Roth 
L-Serine Acros Organics 
L-Threonine Sigma-Aldrich 
 
 
L-Tyrosine Applichem 
Magnesium sulfate (MgSO4) Sigma-Aldrich 
Melatonin powder  Sigma-Aldrich 
Methionine Roth 
α-methyl-DL-aspartate (MeAsp) Sigma-Aldrich 
(−)-Norepinephrine Sigma-Aldrich 
O-xylene Sigma-Aldrich 
Poly-L-Lysine Sigma-Aldrich 
Potassium phosphate monobasic (KH2PO4) Sigma-Aldrich 
Potassium phosphate dibasic (K2HPO4) Sigma-Aldrich 
Leu-Pro hydrochloride Sigma-Aldrich 
Polyethylene glycol (PEG) ThermoFisher 
Proteinase K ThermoFisher 
Putrescine dihydrochloride Sigma-Aldrich 
Serotonin hydrochloride Sigma-Aldrich 
Sodium citrate dihydrate (C6H5Na3O7) Sigma-Aldrich 
Sodium chloride (NaCl) Roth 
Sodium salicylate Sigma-Aldrich 
Spermidine (≥99% purity) Sigma-Aldrich 
Testosterone Sigma-Aldrich 
Thiamine hydrochloride Sigma-Aldrich 
Tris base Roth 
Tryptone Roth 
Yeast Extract Applichem 
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2. Media and buffer solutions 
2.1. Media 
LB  
10 g  Tryptone 
5 g Yeast extract 
5 g  NaCl  
Adjusted to pH 7 and ddH2O was added up to a total volume of 1 L. For preparing LB agar 
plates, 15 g of agar were added to 1 L of LB liquid medium. 
 
TB  
10 g  Tryptone 
5 g  NaCl 
Adjusted pH to 7 and ddH2O was added up to a total volume of 1 L. 
 
Minimal A  
5 x minimal A salts: 
26.25 g  K2HPO4   
11.25 g  KH2PO4                
2.5 g  (NH4)2SO4  
1.25 g C6H9Na3O9 
ddH2O was added up to a volume of 500 mL. 
 
5 mg/mL AA-mix: L-Threonine, L-Histidine, L-Methionine, L-Leucine in ddH2O 
To prepare 100 mL 1 x media: 
20 mL  5 x minimal A salts   
1 mL 20% glycerol 
100 µL  1 M MgSO4                
800 µL 5 mg/mL AA-mix  
200 µL 50 mg/mL thiamine 
 
 
50 mL 0.5 % agar 
27.7 mL ddH2O     
 
SAPI Medium  
1.25 mL  1 M NH4NO3               
370 µL  1 M KH2PO4  
670 µL 1 M KCl 
378 µL 1M glucose 
60 mL Adult bovine serum (30%) 
137,3mL ddH2O 
 
Glycerol-salts Medium  
2 g  Glycerol               
1 g (NH4)2SO4 
9 g KH2PO4 
0.4 g MgSO4 
Adjusted pH to 6.3 and ddH2O was added up to a total volume of 1 L. 
 
2.2. Buffer 
Phosphate buffer  
1.742 g  K2HPO4 
1.361 g  KH2PO4 
0.901 g lactic acid 
Adjusted with NaOH to pH 7 and ddH2O was added up to a total volume of 1 L. 
 
Tethering buffer 
5 mL 1 M K2HPO4 
5 mL 1 M KH2PO4 
0.2 mL 0.5 M EDTA 
0.1 mL 10 mM Methionine 
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1 mL 90% lactic acid 
Adjusted to pH 7 and ddH2O was added up to a total volume of 1L. 
 
Motility buffer 
10 mL 1 M KPO4 
0.2 mL 0.5 M EDTA 
3.91 g NaCl 
Adjusted to pH 7 and ddH2O was added up to a total volume of 1L. 
 
TSS (Transfer Storage Solution) 
200 mL LB 
20 g PEG 4000 
10 mL DMSO 
2.46 g MgCl2 
Adjusted to pH 6.5. 
 
TAE buffer (Tris-Acetate-EDTA - 50 x) 
242 g Tris base 
57.1g  Glacial acetic acid 
100 mL 0.5 M EDTA, pH 8 
ddH2O was added up to a total volume of 1 L. 
 
 
 
 
 
 
 
 
 
2.3. Antibiotic and inducers solutions  
Ampicillin (Amp): 100 mg/mL in ddH2O 
Chloramphenicol (Cam): 34 mg/mL in ethanol 
Kanamycin (Kan): 50 mg/mL in ddH2O 
Tetracycline (Tet): 5 mg/mL in ethanol 
0.1 M IPTG in ddH2O 
10 % L-Arabinose in ddH2O 
100 mM Sodium salicylate in ddH2O 
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3. Bacterial strains 
All strains used in this work are shown in Table 2.  
Table 2: List of strains 
Strains Relevant genotype Source 
MG1655 E. coli RP437 F- (λ-) rph-1 (180) 
RP437 E. coli wild type for chemotaxis (181) 
VS104 E. coli RP437 ∆(cheY cheZ) (26) 
VS149 E. coli RP437 ∆(cheR cheB cheY cheZ) (26) 
VS181 E. coli RP437 ∆(cheY cheZ) ∆tsr ∆tap ∆tar ∆trg ∆aer (26) 
VH1 E. coli RP437 ∆(cheR cheB cheY cheZ) ∆tsr ∆tap ∆tar ∆trg ∆aer (182) 
UU1250 E. coli RP437 ∆(tar tsr trg tap aer) (183) 
∆trg E. coli RP437 Δ(cheR-cheZ) trg::Tn10 (15) 
∆tap E. coli RP437 Δ(cheY cheZ) tap  (8) 
∆potA E. coli BW25113 ΔpotA::KmR, KmR removed This work 
∆potD E. coli BW25113 ΔpotD::KmR, KmR removed This work 
ΔflgM::ΔpotD ∆potD; ∆ tsr tar tap trg aer; ∆ flgM This work 
ΔflgM::ΔpotA ∆potA; ∆ tsr tar tap trg aer; ∆ flgM This work 
∆fhuA E. coli BW25113, JW0146 (184) 
∆fecA E. coli BW25113, JW4251 (184) 
∆fepA E. coli BW25113, JW5086 (184) 
∆fiu E. coli BW25113, JW0790 (184) 
∆cirA E. coli BW25113, JW2142 (184) 
∆fhuF E. coli BW25113, JW4331 (184) 
∆fhuE E. coli BW25113, JW1088 (184) 
∆fur E. coli BW25113, JW0669 (184) 
S. typhimurium  Salmonella enterica subsp. enterica serovar typhimurium 
(ATCC® 14028™) (185) 
EcoR64 E. coli (Migula) Castellani and Chalmers (ATCC® 35383™) (186) 
 
  
 
 
 
 
 
4. Plasmids and oligonucleotides 
All plasmids used in this work are shown in Table 3 and all primers are listed in Table 4 and 
Table 5. 
Table 3: List of plasmids 
Plasmids Relevant genotype Induction Source 
pBAD33  Expression plasmid, CmR  Arabinose (187) 
pKG 166 Expression vector, p15A ori, CmR Sodium 
salicylate 
(188) 
pKG 110 Expression vector, p15A ori, nahG 
promotor, CmR 
Sodium 
salicylate 
Gift from Sandy Parkinson 
pVS88 CheY-EYFP / CheZ-EYFP expression 
plasmid, pTrc99a derivative 
IPTG (8) 
pVS1092 Tar expression plasmid, pKG110 
derivative 
Sodium 
salicylate 
Gift from David Kentner 
pPA114 Tsr expression plasmid, pKG110 
derivative 
Sodium 
salicylate 
(183) 
pcp20 FLP+  (189) 
pJL2 PotD expression plasmid, pKG116 
derivative 
Sodium 
salicylate 
This study 
Tar-Pinhead Δtsr tar tap trg aer; ∆tar (44-
183)=Tar°; cheZ-ecfp / cheY-eyfp 
Sodium 
salicylate 
(190) 
Tsr-Pinhead ∆tsr [L53-V182]; pRR53 derivative IPTG Gift from Sandy Parkinson 
Tsar Hybrid Tsr-Tar expression plasmid; 
pKG116 derivative 
Sodium 
salicylate 
(190) 
Tasr Hybrid Tar-Tsr expression plasmid; 
pKG116 derivative 
Sodium 
salicylate 
(190) 
TarTM Tar TM2 added II before 200V Sodium 
salicylate 
Shuangyu Bi, not published 
TarHAMP Tar[1-266]-GVPQM-[272-553] Sodium 
salicylate 
Shuangyu Bi, not published 
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Table 4: List of primers 
Primers Nucleotide Sequence (5’-3’) 
Restriction 
site 
Target Source 
ERI121  CAGTCATAGCCGAATAGCCT _ KmR cassette 
knockouts 
(191) 
ERI122 CGGTGCCCTGAATGAACTGC _ 
JL01 TGTATTTCTACAACTGGACCGAG _ potD rev This work JL02 GATGATCGTCAAAGCGGTGGT _ potD fw 
JL03 CAAACAACACAAGCCAAC _ potA rev 
potA fw This work JL04 GCTCAAGTAGTTTATCCAT _ 
JL05 GATGATGAAGGGCAAAACAA _ potF rev 
potF fw This work JL06 CAGTTATAAATGTGGAGTGT _ 
JL07  GAATTCTTAACGTCCTGCTTTCAGCT EcoRI potD rev 
potD fw  This work JL08 CATATGATGAAAAAATGGTCACGCCAC NdeI 
JL09  CAGGGGGTGGTGAAAAATCA _ Tsr-Pinhead rev 
Tsr-Pinhead fw This work JL10 TCGCTGATGTACTGACAAGC _ 
 
Table 5: List of primers for real-time qPCR 
Primers Nucleotide Sequence (5’-3’) Target Source 
JL11 GCATTTTCCATTTCGGGTGGT ypdI rev 
ypdI fw This work JL12 GTGGCGCATCTTCTCTCAT 
JL13 GCTACTGCACCGGCAAATA ykfH rev 
ykfH fw This work JL14 GCGTATACCGCGAGGAC 
JL15 CTCCCTCGGCCAGCATC acrS rev 
acrS fw This work JL16 CAATTCCGCTGAAGGCAC 
JL17 GCCGATACTTTCGCAGTCAA yegJ rev 
yegJ fw This work JL18 GTTTGTAACAATACCAGGGTCAT 
JL19 GTCACAGGTTGGCTTCTCATC yfjS rev 
yfjS fw This work JL20 CAAAGCGCATTCATCAGCG 
JL21 GGTTAATGCCATTGAGCAA bdm rev 
bdm fw This work JL22 CACTGAGGATGTCGTTATC 
JL23 GACCTGATCATTGCCGACA fecB rev 
fecB fw This work JL24 GTGCCTGCATCTCTCGCT 
JL25 GCTTTCACTGGCTCCCGTT fecA rev 
fecA fw This work JL26 CTCGATACCAAAGTCCTGCGG 
JL27 GCCTGCCGTGGAAATATTATGA tdcD rev This work JL28 CACTCTGACCGTTGCGAA tdcD fw 
JL29 TTTGATATCTCTCGCCCGGC tdcE rev This work JL30 GATCAGTTCCTGTGCCTGCT tdcE fw 
JL31 GCAATTCGGCTGGACTAAT ynak rev This work 
 
 
JL32 CAGAATCCATTTTGAGCATTTC ynak fw 
JL33 AACAACGAATCCCTGGTGTG ydaF rev 
ynak fw This work JL34 CTGTGTGCTTCTCCAACCAT 
JL35 ACTCTGTCATTTGGCGTGTT ybiJ rev 
ybiJ fw This work JL36 TTTCTCAGCCAGTTTCGCTT 
JL37 CTATGCCTCCCTGCGTGT yhaK rev 
yhaK fw This work JL38 CTGAACATGATTGCCTTCGCT 
JL39 AACCAACCGATGATGATCCG fhuF rev 
fhuF fw This work JL40 TTCCGGCGACACATCTAATG 
JL41 CAATCATGGAAAAGGCTTAC ydfB rev 
ydfB fw This work JL42 GAACTGGAAAGCGCCT 
JL43 ATCATCGTCAGAGAGCTGCG qseC rev 
qseC fw This work JL44 GAACGACGCTTTACCTCCGA 
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5. Molecular cloning 
5.1. Polymerase Chain Reaction (PCR) 
The PCR reactions were performed in the thermocyclers TPersonal (Biometra) and peqSTAR 
(PEQLAB). The resulting fragments were analyzed in a 1% TAE-agarose gel and purified with 
the GeneJET DNA Purification Kit or the GeneJET Gel Extraction Kit. 
 
Single Colony PCR 
25 μL DreamTaq Green PCR Master Mix (2x) 
1 μL forward primer (10 pmol/ μL) 
1 µL reverse primer (10 pmol/ μL) 
 colony picked from plate  
up to 50 μL ddH2O 
  
Thermocycler settings 
 
 
 
 
 
 
 
PCR with Q5 polymerase  
10 μL Q5 reaction buffer 
2.5 μL forward primer (10 pmol/ μL) 
2.5 μL  reverse primer (10 pmol/ μL) 
1 μL  dNTPs (10 mM) 
0.5 μL  Q5 high fidelity DNA polymerase 
1 μL  template DNA 
95 °C  3 min 
95 °C 30 sec 
55 °C 30 sec       
72 °C variable (1 min/ 1 kb) 
72 °C 5 min 
30 cycles 
 
 
up to 50 μL ddH2O 
 
Thermocycler settings 
 
 
 
 
 
 
 
PCR with PrimeSTAR GXL polymerase  
10 μL 5 x PrimeSTAR GXL Buffer 
1 μL forward primer (10 pmol/ μL) 
1 μL  reverse primer (10 pmol/ μL) 
1 μL  dNTPs (10 mM) 
0.5 μL  PrimeSTAR GXL DNA Polymerase 
1 μL  template DNA 
up to 50 μL ddH2O 
 
Thermocycler settings 
 
 
 
 
 
 
 
 
 
98 °C  30 sec 
98 °C 10 sec 
Variable temperature 30 sec       
72 °C variable (1 min/ 1 kb) 
72 °C 2 min 
98 °C  30 sec 
98 °C 10 sec 
Variable temperature 30 sec       
72 °C variable (1 min/ 1 kb) 
72 °C 2 min 
30 cycles 
30 cycles 
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5.2. Competent cells 
For producing competent cells, two different procedures were used: chemical method and 
one-step preparation. 
 
5.2.1. Chemical competent cells with calcium chloride 
For the chemical method, 1 mL cells of an LB overnight culture were diluted into 100 mL 
fresh LB media and grown at 37 °C to an OD600 = 0.6. After harvesting the cells by 
centrifugation for 5 min at 4000 rpm, the pellet was resuspended in 10 mL ice-cold 0.1 M 
CaCl and incubated on ice for 20 min. Cells were centrifuged for 5 min at 4000 rpm and the 
pellet was resuspended in 5 mL ice-cold 0.1 M CaCl2, followed by another 20 min on ice. 
Next, cells were centrifuged as previous and resuspended in 1 mL TB with 20% glycerol and 
aliquoted. The aliquots were treated with liquid nitrogen and frozen at -80 °C.  
 
5.2.2. One-step preparation of competent cells 
Chung et al. (192) developed a one-step procedure for the preparation of competent 
Escherichia coli cells, which use a transformation and storage solution (TSS). This is a much 
faster method, especially useful when just small amounts of competent cells are needed. 
100 µL of a LB overnight culture of the cells were diluted in 3 mL fresh LB medium and 
grown at 37 °C to an OD600 = 0.6. The cells were cultured 20 min on ice. 1 mL of culture was 
centrifuged at 8000 rpm for 1 min and resuspended in 100 µL of TSS. The cells were then 
ready for transformation with the desired plasmid. 
 
5.3. Transformation 
Heat shock 
0.5 μL plasmid DNA or 5μL ligation were mixed gently with 100 μL chemical competent cells 
in a 1.5 mL reaction tube and kept on ice for 30 min. For heat shock, the sample was heated 
to 42°C for 45 s in a heating block. After the heat shock, the tube was immediately placed 
 
 
on ice for 5 min. 900 μL of LB medium were added and the cells were incubated at 37 °C. 
After 45 min, cells were harvested and plated on LB agar plates with selective antibiotics. 
Plates were incubated over night at 37 °C. 
 
5.4. Restriction 
Enzymes used for restriction digests were EcoRI and NdeI from Fermentas (Massachusetts, 
United States). 
Preparative restriction digest was performed using  
10 μL Template DNA 
3 μL 10x Restriction buffer 1 μL   
1 μL  restriction enzymes (if same activity in double digestion) 
15 μL  ddH2O  
Mixture was incubated for 2-3 h at 37 °C. 
 
5.5. Ligation  
Ligations were performed at room temperature for 1 h or at 16 °C overnight.  
 
Ligation system 
Vector DNA  1 - 2 μL (10 - 20 ng)  Variable, according to DNA concentration  
Insert DNA  3 - 5 μL (50 -100 ng)  Variable, according to DNA concentration  
10 x Ligase 
buffer  
2 μL 1 x  
Ligase  1 μL 1 U  
ddH2O  up to 20 μL  
 
Followed by heat inactivation at 65°C for 10 min. 
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5.6. Gene deletion strains derived from Keio collection 
The kanamycin resistant single-gene deletion strains of the Keio collection were used as 
donor strains for P1 phage transduction (193), into the MG1655 background. The resulting 
strains were tested for correct insertion of the FRT-site flanked kanamycin cassette into the 
genome, using gene and kanamycin cassette specific primers, ERI121 and ERI122 (Table 4). 
The kanamycin cassette was removed from the deletion strains using the temperature 
sensitive pCP20 plasmid encoding a FLP recombinase (189) and tested for the loss of 
antibiotic resistance after several rounds of growth on LB plates at 42°C. The resulting 
strains carry an 82-85 nucleotide scar in place of the disrupted gene (194). 
 
5.7. Plasmid cloning by PCR 
To determine the effect of PotD, the plasmid pJL2 was constructed. The gene potD was 
amplified using the primers JL07 and JL08. The resulting fragment was digested with EcoRI 
and NdeI and ligated to pKG116. The pJL2 plasmid was used to complement ∆potD strain. 
To verify the correctness of the sequence, the purified plasmid DNA was sent for 
sequencing to the Eurofins MWG Operon (Ebersberg) company. Sequences were analyzed 
using the program ContigExpress of the Vector NTI advance suite 11 software (Invitrogen). 
  
 
 
 
 
 
 
 
 
 
 
 
 
6. RNA Isolation and Deep Sequencing 
RNA was isolated with the EURX GeneMATRIX Universal RNA Purification kit. Overnight 
cultures were grown in 5 mL TB medium at 30 °C at 200 rpm, from which 100 µL were 
inoculated into 10 mL of TB medium, with and without the tested compounds. These day 
cultures were grown at 37°C to early exponential phase. The isolation was performed 
according to the supplier’s manual and, after a treatment with the TURBO DNA-free kit, 
tested for degradation on a formaldehyde gel. The samples were depleted for rRNA and 
sequenced at the Max Planck-Genome center, Cologne. 
 
6.1. RNA sequencing data 
The data analysis of the RNA sequencing project was performed in the ArrayStar program 
using student’s t-test for statistical analysis and the Benjamini Hochberg procedure for 
multiple testing correction. Genes with a linear expression level <1 in either of the samples 
were excluded from the data sets to perform quantile normalization. Genes with a log2 
expression level < 1 have a low number of unique mapped reads and were excluded from 
the analysis as well.  
For the analysis of the MG1655 RNA sequencing project the mean expression value of the 
duplicates was calculated. To study variations in the expression levels of genes between 
different experiments we use the fold change between one experiment serving as a control, 
where no supplements were added, and the second experiment, where the desired 
compounds were added. Fold changes are often depicted in tables or scatter plots. Tables 
list the logarithm of the ratio of expression in presence and in absence of the compound. In 
the scatter plot dot each dot represents a gene, its abscise being the log of the gene 
expression in absence, and its ordinate in presence, of the compound, where a fold change 
of 0 represents no changes in the gene expression between the two experiments and 
appears on the identity line in the middle of the plot. A fold change more than 2 can be 
found outside the fold lines parallel to the identity line of the scatter plot. Genes 
upregulated in comparison with the control experiment have a positive value in tables and 
can be found in the upper half of the scatter plot. Consequently, genes on the lower half of 
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the plot are downregulated in comparison with the control experiment and have a negative 
value in tables (Appendix-Figure 2). 
 
6.2. Reverse transcription polymerase chain reaction quantitative real time: qRT-PCR 
All samples to be compared were processed in parallel and 3 replicas of the same sample 
were performed. PCR reaction was done with 96 well plates (MicroAmp) covered with 
optical adhesive covers (Applied Biosystems). The instrument used was ABI PRISM 7700 
Sequence Detection System or ABI PRISM 7000 Sequence Detection System (Applied 
Biosystems). The reference gene used for the experiments was rssA, that has been shown to 
be the most stably expressed gene under osmotic and acid stress in E. coli (195). Reaction 
master mix was made according to KAPA SYNR FAST one-step qRT-PCR protocol. KAPA SYBR 
FAST One-Step qRT-PCR Kits contain M-MuLV Reverse Transcriptase, RNase Inhibitor and a 
novel DNA Polymerase engineered via molecular evolution. The kit is optimized for rapid 
one-step, one-tube RNA quantification. The qRT-PCR reactions were carried out in a total 
volume of 5 µL containing: 
 
0.025 μL RT PCR Dye (200x) 
0.2 μL Nuclease-free water  
2.5 μL  KAPA SYBR FAST qPR Master Mix (2x) 
0.1 μL  Forward primer (10 µM) 
0.1 μL  Reverse prime (10 µM) 
0.1 µL KAPA RT Mix (50x) 
2 µL Template RNA (1 ng/µL) 
 
Relative gene expression levels were calculated using the comparative Ct method. 
 
 
 
 
 
7. Reaction kits 
The kits were used according to the guidelines given by the manufacturers. 
• GeneJET DNA Purification Kit, ThermoFisher Scientific, Dreieich 
• GeneJET Gel Extraction Kit, ThermoFisher Scientific, Dreieich 
• GeneJET Plasmid Miniprep Kit, ThermoFisher Scientific, Dreieich 
• Q5 Site-Directed Mutagenesis Kit, New England BioLabs GmbH, Frankfurt a.M. 
• EURX GeneMATRIX Universal RNA Purification Kit, Roboklon GmbH, Berlin 
• TURBO DNA-free Kit, Ambion ThermoFisher Scientific, Dreieich 
• KAPA SYBR FAST One-Step qRT-PCR Kit, KAPA Biosystems, Wilmington, Massachusetts 
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8. Microscopy 
To investigate the chemotactic responses of E. coli to the studied gut compounds, three 
different microscopy techniques were performed: flow-FRET, a microfluidic assay and a 
chemotactic drift assay. 
 
8.1. Stimulus-dependent ratiometric FRET (flow-FRET) 
The intracellular response of the chemotaxis pathway of E. coli was monitored using a 
method based on the Förster (fluorescence) Resonance Energy Transfer (FRET), between 
two fluorescent proteins in close proximity, when the emission band on the first covers the 
absorption band of the second (26). The assay relies on the phosphorylation-dependent 
interaction between CheY fused to yellow fluorescent protein (CheY-YFP) and its 
phosphatase CheZ fused to cyan fluorescent protein (CheZ-CFP) (8, 26). The FRET pair CheY-
YFP and CheZ-CFP was expressed from pVS88, a bi-cistronic construct (8). When CheY is 
phosphorylated FRET occurs because CheY-YFP and CheZ-CFP are in close proximity, leading 
to a decreased YFP emission and an increased CFP. A decreased level of phosphorylation 
leads to a reduced interaction, decreasing YFP emission and increasing CFP emission. To 
minimize effects of absolute fluorescence changes due e.g. to illumination fluctuations, the 
amount of FRET is quantified by the ratio YFP/CFP. Binding of attractant to receptors 
inhibits the kinase activity of CheA, leading to a decrease in FRET. This decrease in FRET is 
observed as a decrease in the YFP/CFP ratio due to the reduced numbers of CheY-P-CheZ 
complexes. Conversely, removal of attractant or binding of repellents to the receptors leads 
to an increase in the YFP/CFP ratio. Hence, the YFP/CFP ratio gives a direct readout of 
intracellular changes of kinase activity upon stimulation (Appendix-Figure 1). Microscopy 
setup for the FRET measurements is shown in Figure 10. Measurements were performed as 
described before on custom-modified Zeiss Axiovert 200 or Axio Imager Z1 microscopes (25, 
26, 196).  
 
 
 
Figure 10: Flow-FRET assay apparatus. The microscopy setup is shown for a Zeiss Axiovert 200 microscope 
(Figure adapted from (196)). 
 
8.1.1. Preparation of cells 
Overnight cultures were grown in 10 mL (in flasks) TB supplemented with appropriate 
antibiotics at 30°C. 10 mL day culture were prepared with 250 µL from overnights cultures 
and grown in a rotary shaker at 34 °C and 275 rpm, supplemented with appropriate 
antibiotics and inducers. Cells were harvested at OD600 0.6. by centrifugation (4000 x g for 5 
min), washed with tethering buffer and stored at 4°C for 30 min to inhibit protein synthesis. 
Circular coverslips (Ø 12mm) were prepared with 20 μL of poly-L-lysine and let stand for 20 
min. To prepare the samples for FRET measurements, 1.5 mL cell culture were centrifuged 
at 8000 rpm for 1 min and the cell pellet was resuspended in 20-40 µL residual tethering 
buffer. The concentrated cells were attached to a poly-lysine-coated coverslip for 10 min 
and then placed into a flow-chamber that was maintained under a constant flow (0.3 
mL/min) of tethering buffer using a syringe pump (Harvard Apparatus).  
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8.1.2. Data acquisition and analysis 
The sample was excited at a CFP-specific wavelength of 436/20 nm by a 120W Hg-Lamp 
(EXFO X-Cite® 120) attenuated 500-fold with neutral density filters (upright microscope) or a 
75W Xenon lamp (Hamamatsu, Bridgewater, NJ) attenuated 550-fold by neutral density 
filters (inverted microscope). A 455 nm dichroic mirror served to separate excitation from 
emission light and a second, 515 nm dichroic mirror was used to split up emission light in 
two spectral parts per second. Cells were focused with a 40x objective (Zeis Plan-Neofluar 
40x/0.75) and a section of a dense and unitary monolayer comprising 500-600 cells was 
chosen for experimentation. Fluorescence of the cells was continuously recorded in the 
cyan and yellow channels using photon counters with a 1.0 s integration time and a PCI-
6034E counting board connected to a computer with LabView7/Template software was 
used for data acquisition as counts of detected photons per second. Cells were allowed to 
adapt to the tethering buffer for at least 10 min. To stimulate the cells, solutions of different 
stimuli or buffer at different concentrations (see Figure 10) were rapidly exchanged with the 
buffer reservoir, and the change in YFP/CFP ratio was monitored for about 100 seconds for 
a dose response and 2-20 min for adaptation measurements.  
The response was tested by stimulating cells expressing the FRET pair with serial dilutions of 
chemicals and measuring the subsequent change in the FRET ratio (i.e., the ratio of the YFP 
to CFP fluorescence emission). Stimulation with an attractant results in a rapid decrease in 
the FRET ratio, while stimulation with a repellent has an opposite effect. Because 
continuous stimulation elicits adaptive changes in receptor methylation that gradually 
offset the effects of either attractant or repellent, the FRET ratio typically transiently 
overshoots upon removal of the chemoeffector (Appendix-Figure 1) (8, 26).  
FRET response was measured as the change in the ratio of YFP/CFP and normalized to the 
ratio change of buffer-adapted cells responding to saturating stimulation with chemical 
attractant, either α-methyl-DL-aspartate (MeAsp) or L-serine or O-xylene. 
Thus, FRET can be calculated from the changes in the ratio of YFP and CFP signals as 
followed: 
 
 
 
𝐹𝐹𝐹𝐹 = ∆𝐹𝑀𝑀𝑀 − ∆𝐹 
𝛼 + 𝐹0 +  ∆𝐹𝑀𝑀𝑀 −  ∆𝐹 
 
where ΔR is the change in the ratio due to energy transfer, ΔRMax is the maximal change in 
the ratio due to saturation amount of stimulus and R0 is the ratio in the absence of FRET. 
The constant α is the ratio of the absolute changes of YFP over CFP fluorescence signals due 
to energy transfer, which is dependent on the respective sensitivities of CFP and YFP signal 
detection. 
 
8.1.3. Preparation of stimulus solutions 
Chemical solutions were prepared in tethering buffer at a concentration of 100 mM or at 
the highest possible concentration if the solubility is poor. The pH of all solutions was 
adjusted to pH 7.0 and solutions were stored at 4 °C. For the solutions, which oxidized, fresh 
solutions were prepared each time on the day of the experiment. 
 
8.2. Microfluidics assay 
The microfluidics assay was performed as previously described (197) E. coli UU1250 
expressing GFP proteins were grown at 34 °C in TB supplemented with antibiotics and 
inducers until the OD600 reached 0.6. Cells were harvested by centrifugation at 3000 rpm for 
3 min and washed twice with tethering buffer. The compounds were dissolved in tethering 
buffer and adjusted to pH 7.0.  
 
8.2.1. Chamber fabrication 
For the chamber fabrication, we used a chip with 8 parallel units, as previously described 
(197). The distance between each unit is 9 mm, each unit has two wells at the ends serving 
as source and sink. The diameter of each well is 4 mm, and the volume is about 30 µL. On 
the source side, there are 20 parallel channels (5 µm wide and 300 µm long) which are filled 
with agarose gel (named as agarose gel channel), and on the sink side there is a channel 
(200 µm wide and 600 µm long) which is free for cell swimming (observation channel). The 
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agarose gel channel is 5 µm high while the observation channel is 20 µm high, which is 
fabricated using a standard two-layer photolithography method (Figure 11). After the SU-8 
master is prepared on the silicon wafer, Poly-di-methylsiloxane (PDMS), a bicomponent 
silicone elastomer (SYLGARD 184, 1:10 crosslinker to base ratio, Dow Corning, USA), was 
cast freshly mixed and let to polymerize on the master by overnight heating at 65 °C, peeled 
off, cut to shape and bonded on a glass slide after oxygen plasma treatmentwe. After the 
agarose gel based semi-permeable channel is set up, 30 µL chemotaxis buffer was added 
into the wells. As the surface is hydrophilic and PDMS can re-absorb gas within 1 h after the 
plasma treatment, the chemotaxis buffer solution will flow into the observation channel 
from the sink side well and press out the tracked air in the observation channel. The 
prepared device can be stored in a liquid environment before being used. 
 
 
Figure 11: (A) A panoramic picture of the microfluidic chip. (B) The top view and the side view of the 
observation channel and agarose gel channel. (C) Agarose gel filling process. Figure from (197). 
 
8.2.2. Data acquisition 
E. coli cells were added at the sink side well of the device to a final OD600 of 1.2−2 and 
equilibrated for 40 min in the observation channel. Compound solutions were added at the 
source side well and allowed to diffuse into the observation channel for an indicated time to 
 
 
establish a concentration gradient. Fluorescence microscopy on a Nikon Ti-E microscope 
system (Nikon Instruments Europe BV, Amsterdam, Netherlands) with a 20× objective lens 
was used to detect the fluorescence intensity of cells in the right side of the channel. 
Cellular response was characterized by the fluorescence intensity in the analysis region (300 
μm × 200 μm) of the observation channel. Data were analyzed using ImageJ (Wayne 
Rasband, National Institutes of Health, USA). 
 
8.3. Chemotactic drift assay 
The measurement of the chemotactic drift was performed as previously described (198). 
Cells harvested at mid-exponential growth phase were harvested by centrifugation (4000 
rpm for 5 min), washed with motility buffer and stored at 4°C for 30 min to inhibit protein 
synthesis. Afterwards, the sample was placed in the chamber (see below). After 30 min, a 
linear gradient of chemoattractant is formed in the channel to which the cells respond.  
 
8.3.1. Chamber fabrication 
The chemotaxis chambers were made by bonding glass slides and PDMS chips shaped on a 
SU8 master mold prepared by photolithography, similarly to the previous technique. They 
consisted of two reservoirs (0.5 ± 0.1 cm2 × 50 ± 2 μm) linked via a small channel (length L = 
2 mm, width w = 1 mm) (Figure 12). The chambers were loaded by filling one chamber with 
suspended bacteria and the other suspended bacteria mixed with the target compound at 
the indicated concentration c0. After filling the chamber, its openings were sealed with 
petroleum jelly. 
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Figure 12: Experimental set-up for measurement of chemotactic drift (A). Scheme of the experimental 
sample chamber made of two reservoirs, containing attractant concentrations c = c0 and c = 0 (B). The 
reservoirs are in contact through a narrow channel in the center highlighted by the orange rectangle. (B) Zoom 
on the channel in which a gradient of attractant forms, visualized here using the fluorescent dye fluorescein. 
The red square indicates the area of measurement. White scale bar is 500 µm. Figure from (198). 
 
8.3.2. Data acquisition 
The sample was kept at room temperature (20 ± 1°C) and the bacteria were observed with a 
Nikon microscope equipped with a 10× objective (NA 0.3), under phase contrast 
illumination. The movement of the bacteria was recorded in the middle of the channel using 
a Mikrotron EoSens 4CXP camera running (Mikrotron GmbH, Unterschleissheim, Germany) 
at 100 Hz for 100 s, with a 512 × 512 px2 (722 × 722 μm2) field of view and piloted by a 
Matrox Radient eV-CXP frame grabber (Matrox Electronic Systems Ltd., Dorval, Quebec, 
Canada) and the software StreamPix 7 (NorPix Inc., Montreal, Quebec, Canada). The focal 
plane was chosen halfway 0through the 50 ± 2 μm depth of the sample. Background images 
were computed by time averaging the movie and subtracted from each frame. The relative 
gradient is set by the fixed geometry (length) of the channel and constant for all 
experiments. A high throughput computer analysis of the films yielded the average 
 
 
chemotactic velocity of the population vch, the population averaged swimming speed of the 
swimming cells v0 and the fraction of swimming cells, α, which enables to estimate the 
chemotactic bias vch/αv0, where zero corresponds to non-responding cells and one to a 
population where all cells swim directly down the gradient. 
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9. Growth experiments 
E. coli cells from an overnight culture (37°C and 200 rpm in TB) were diluted until OD600 0.05 
in a total volume of 110 µL of TB medium was supplemented with the analyzed compounds 
in a 96-well plate (Greiner Bio-One, Frickenhausen, Germany) and OD600 was measured in a 
plate reader (Tecan Infinite M1000, Tecan Deutschland GmbH, Crailsheim, Germany) for 
14h at 37°C and 180 rpm. For the dopamine experiments, an additional baseline subtraction 
was required, obtained from a well containing TB supplemented with dopamine at the 
required concentration and no added cells.  
 
9.1. Growth analysis 
Growth was analyzed calculating the area under the curve divided by the duration for each 
individual experiment (14h), yielding a time averaged OD. For each experiment, the time 
averaged OD was normalized to the time-averaged OD of the control culture in TB (Figure 
13). Statistical analysis was performed to assess the difference to the control with a one-
tailed student t-test, p-values lower than 0.05 were considered statistically significant.  
 
 
Figure 13: Example of growth curve analysis. The time-averaged OD was calculated as the area below the 
curve (grey area) divided by the duration of the experiment. For each experiment, the time averaged OD was 
normalized to the time-averaged OD of the control culture in TB (red dashed line). 
 
 
 
9.2. Colony Forming Unit (CFU) assay 
To test the effect in growth of dopamine, CFU assay was performed. E. coli cells from an 
overnight culture (37°C in TB) were diluted 1:100 in a total volume of 10 mL, mixed with 
dopamine at concentrations between 0-10 mM for 6 h. Cells were serial diluted until 10-6 
and 10-7 and 100 µL of the samples were plated on LB plates; each concentration was plated 
in triplicates. Plates were left at 37°C overnight. The number of colonies in each plate was 
counted and the CFU/mL (number of colonies/volume of inoculation x dilution) was 
calculated. 
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RESULTS 
1. Chemotaxis to gut compounds 
1.1. Chemotactic response of wild-type E. coli 
To analyze the possible chemotactic response of E. coli to gut compounds, we performed 
three different assays. We first investigated the response intracellularly with the FRET assay. 
Second, we used a simple phenotypic swimming technique that measures the fluorescent 
intensity by the accumulation of bacteria in the end of the observation chamber. And third, 
a more sophisticated assay that measures the chemotactic drift by following the motion of 
thousands of individual bacterial cells was performed. 
 
1.1.1. FRET assay 
As previously referred (see Material and Methods), the Förster (fluorescence) Resonance 
Energy Transfer (FRET) assay relies on the phosphorylation-dependent interaction between 
CheY fused to the yellow fluorescent protein (CheY-YFP) and its phosphatase CheZ fused to 
the cyan fluorescent protein (CheZ-CFP, Appendix-Figure 1) (8, 26), which allows to measure 
the intracellular pathway response to chemotactic stimuli.  
 
1.1.1.1. Catecholamines 
The intracellular response of the E. coli chemotaxis pathway to the catecholamine group, 
the most widely studied compounds in molecular endocrinology, was first analyzed. In order 
to determine whether E. coli responds specifically to the compounds present in the gut, or 
rather to compounds with similar chemical structure, all players of the biosynthetic 
pathway for catecholamines were analyzed (Figure 3). 
We did not observe a chemotactic response to L-tyrosine, consistent with previous work 
(190), and there was also no substantial response to L-3,4-dihydroxyphenylanine (L-DOPA) 
(Appendix-Figure 3A). Notably, although L-tyrosine and L-DOPA can be detected in the GI 
 
 
tract, these precursors are rapidly converted into dopamine in the gut lumen and therefore 
unlikely to form stable gradients (127, 199, 200). 
In contrast, the two major neurotransmitters of the catecholamine pathway, dopamine and 
NE, elicited biphasic responses. Dopamine was sensed as a repellent when cells were 
stimulated with concentrations below 1 mM, since the FRET ratio increased upon addition 
of dopamine, and decreased upon its removal. In addition, at high concentration (10 mM 
dopamine), the response changed to attractant, similar to the MeAsp response (Figure 14A, 
B).  
The response to NE was generally less pronounced, and it had an inverse pattern compared 
to the dopamine response. NE responded as a weak attractant at low concentrations, as 
previously reported (75, 76), but produced a repellent response above 1 mM (Figure 14C, 
D). The response to DHMA was similar, but stronger than the NE response, with a very weak 
attractant response until approximately 50 µM that at higher concentrations changed to a 
strong repellent response (Figure 14E, F). An attractant response to DHMA had also been 
previously observed in the same study, and it was concluded that the NE response observed 
was actually due to its conversion to DHMA (75) 
Lastly, we analyzed the response to epinephrine, the last compound in the catecholamine 
pathway. Though epinephrine elicited a repellent response (Appendix-Figure 4), 
interpretation of these data was complicated due to a strong autofluorescence of 
epinephrine that interfered with FRET measurements, and we instead used microfluidics to 
assess the chemotaxis response to epinephrine (see section 1.1.2).   
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Figure 14: Typical chemotactic pathway response for wild type to dopamine (A), norepinephrine (NE) (C) 
and 3,4-dihydroxymandelic acid (DHMA) (E). The ratio of YFP/CFP fluorescence reflects the activity of the 
chemotaxis pathway. Buffer-adapted cells were stimulated with step-like addition and subsequent removal of 
compounds, indicated by downward and upward arrows, respectively. Saturating stimulation with 1 mM α-
methyl-DL-aspartate (MeAsp) was used as a positive control. Dose responses of wild-type cells to dopamine 
(B), NE (D) and DHMA (F). Each point represents the mean FRET-measured values of the kinase activity, 
normalized to the baseline in buffer, from at least three independent experiments, with error bars indicating 
the standard error of the mean. Values above one correspond to a repellent response, while values below one 
correspond to an attractant response, as indicated. 
 
1.1.1.2. Thyroid hormones 
We analyzed the responses of the two major thyroid hormones, serotonin and melatonin 
(Figure 4). E. coli was previously shown to not respond to the precursors of the thyroid 
hormones, L-tryptophan (190). While no significant chemotactic response was observed for 
serotonin (Appendix-Figure 3B), wild-type E. coli cells exhibited strong dose-dependent 
repellent response to melatonin, at concentrations above 0.1 mM (Figure 15A, B). The lack 
of response towards serotonin was surprising, since it is present in the enterochromaffin 
cells of the gastrointestinal mucosa and within neurons in the enteric nervous system (201) 
and therefore available in high concentration in the gut, where it plays a role in microbial 
endocrinology (202-204). 
 
Figure 15: Typical chemotactic pathway response (A) and dose response (B) of wild type to melatonin, 
performed as in Figure 14.  
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1.1.1.3. Polyamines 
Among the two tested polyamines, putrescine and spermidine, E. coli did not exhibit any 
significant response to putrescine (Appendix-Figure 3B), consistent with the fact that 
putrescine does not accumulate in the GI lumen since it is rapidly taken up or converted to 
spermidine and spermine in the small intestine (205). In contrast, we observed a strong 
repellent response to spermidine in the millimolar concentration range (Figure 16A, B). The 
exact concentration of spermidine in the gut lumen is still unclear, but it is believed that it 
can reach tens to hundreds of micromolar concentration (140).  
 
 
Figure 16: Typical chemotactic pathway response (A) and dose response (B) of wild type to spermidine, 
performed as in Figure 14. 
 
1.1.1.4. Other hormones: β-estradiol, testosterone and insulin 
Additionally to the above described compounds, we analyzed other hormones that may be 
present in the human gut, the sex hormones β-estradiol and testosterone, and insulin.  
While we did not observe a response for β-estradiol, a strong repellent response was 
observed for testosterone (Figure 17). This response is likely to be related to membrane 
stress, since testosterone is a product of cholesterol that is known to interfere with the 
 
 
membrane of E. coli (206). The real concentration of sex hormones in the GI tract in 
unknown, but several reports describing interactions between bacteria and sex hormones 
have reported (147, 148). 
 
 
Figure 17: Typical chemotactic pathway response for wild type to testosterone (A), performed as in Figure 
14. 
 
Interestingly, we observed a biphasic response for insulin that changed from attractant to 
repellent, around 1mM, possibly due to the development of some toxic effect at high 
concentrations (Figure 18). Since insulin is much larger than other E. coli ligands (5.8 KDa, 
compared with e.g. dopamine ≃ 0.19 KDa or aspartate ≃ 0.13 KDa), it was surprisingly that 
we obtained a chemotactic response. Insulin is composed of two peptide chains referred to 
as the A-chain and B-chain. A- and B-chain are linked together by two disulfide bonds, and 
an additional disulfide is formed within the A-chain. In most species, the A-chain consists of 
21 amino acids and the B-chain of 30 amino acids (Figure 6). Degradation of commercial 
insulin due to shaking and high temperatures, specially by deamination, has been previously 
described (207). To ensure that the observed response was not due to amino acid residues 
or residues in the insulin buffer, we partial digested and denatured insulin, to determine if 
the chemotactic response changed. Insulin was denatured at high temperatures (95°C) and 
digested with proteinase K. Although the response to insulin did not ceased with the 
denatured insulin, it shifted from repellent to attractant at 1 mM (Figure 18). The results to 
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digested insulin were inconclusive because proteinase K, which could not be entirely 
removed from the solution, interfered with the FRET signal (data not shown). Additionally, 
we analyzed the response to only the A-chain of insulin (Figure 18). The pathway responded 
to the A-chain of insulin only at 1 mM. The A-chain of insulin elicited a slightly weaker 
repellent response than the intact insulin at this concentration (Appendix-Figure 5). These 
results support the hypothesis that the repellent response observed at this range is specific 
to insulin and that the attractant response, obtained with denatured insulin, is due to the 
presence of single amino acids.  
Taken together, E. coli senses insulin as an attractant that shifts its response to repellent at 
high concentrations. However, the attractant response at lower concentrations is likely due 
to degradation of amino acids. Nevertheless, this response needs to be further investigated 
and confirmed.  
 
Figure 18: Dose responses of wild-type cells to filtered insulin (circles), insulin A-chain (triangle) and 
denatured insulin (square), performed as in Figure 14. 
 
 
 
 
 
1.1.2. Microfluidic assays  
To confirm the FRET results we analyzed the chemotactic behavior of E. coli to gut 
compounds with two different microfluidic assays. 
In the first assay, the responses of wild-type cells to catecholamines were tested in 
microfluidic channels. The microfluidic device used has a gel-based membrane that 
prevents bacteria to get across, but permits the diffusion of small molecules, in a flow-free 
channel that generates a concentration gradient for bacterial chemotaxis (see Material and 
Methods).  
Although the observed attractant chemotactic behavior were consistent with the FRET data, 
repellent responses were more difficult to detect. Since dopamine elicits biphasic responses 
at different concentrations, the wild-type cells were tested in gradients of 0, 1 and 10 mM 
of dopamine. As shown in Figure 19, the highest concentration produces a strong attractant 
response, as in FRET, opposite to the weak response observed at 1 mM. Correspondingly, 
the response to NE in the wild type was less obvious, when compared to the repellent 
response in FRET. The response to DHMA for the wild-type strain was in agreement with the 
obtained repellent response in FRET (Figure 19).  
 
 
Figure 19: (A) Typical examples of the chemotactic response in microfluidic assay to 1 mM of MeAsp and to 
1 and 10 mM of dopamine. The arrow on the image indicates the direction up the concentration gradient of 
each ligand, where the highest concentration of ligand is located on the right edge of the observation 
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chamber. The response is characterized by measurements of the fluorescence intensity in the end of the 
observation chamber, indicated by a yellow rectangle (300 μm × 200 μm). (B) Relative fluoresce intensity 
values of the tested compounds to wild-type cells. The values of the fluorescence intensities in the referred 
area 30 min after ligand addition were normalized to the fluorescence intensity at time 0. The highest 
concentration analyzed was 10 mM of dopamine, all the remaining compounds were analyzed at 1 mM of 
concentration. Values above 0 correspond to an attractant response, while values below 0 correspond to a 
repellent response, as indicated. For the positive control, the fluorescent intensity was measured in a gradient 
of 1 mM MeAsp and buffer was used as a negative control. Error bars indicate the standard error of the mean 
of at least three independent measurements. 
 
To get further insights into the motion of a bacterial cell population we used a different 
technique, the chemotactic drift assay. This assay applies a recently described technique 
that allows measurements of the average motion of a bacterial population in linear 
chemical gradients, characteristic for chemotaxis (198, 208). The observed chemotactic 
behavior was consistent with the FRET responses for the wild-type strain (Figure 20). The 
wild-type strain showed repellent response to all tested hormones in the 0 to 1 mM 
gradient, similar to the dominant response observed in this concentration range by FRET. 
For epinephrine, we observed an attractant response, consistent with a previous report 
(76). In addition, melatonin showed a repellent response, consistent with the FRET data. 
Finally, the wild type showed a strong repellent response to spermidine. Although the 
observed chemotactic drift away or towards the gut compounds was overall weaker than 
the drift in gradients of MeAsp (198, 208), it was similar to chemotaxis observed towards 
metabolized strong attractants of Tar or Tsr, aspartate and serine, respectively. 
Furthermore, statistical analysis was performed to confirm the difference between the 
chemotactic drift responses and zero, which corresponds to non-responding cells. The wild-
type cells showed statistically significant responses towards all tested compounds, what 
suggests that degradation of attractants generally weakens the response that can be 
measured using this microfluidic assay, which is not surprising given the relatively high 
density of bacteria within the channel in these experiments. 
 
 
 
 
Figure 20: Chemotactic response in gradients of gut compounds. Chemotactic drift (see Material and 
Methods) was measured in gradients of dopamine, NE, DHMA, Epinephrine, Melatonin or Spermidine 
established in a microfluidic device. Zero chemotactic drift corresponds to non-responding cells and one to 
direct swimming up (negative values) or down (positive values) the gradient. For the negative control, drift of 
the wild-type cells was measured in buffer in absence of gradients. For the positive control, the drift was 
measured in a gradient of 0 to 1 mM aspartate (Asp.) for the wild type. As a reference (not shown), the 
chemotactic drift of the wild-type cells in a gradient of non-metabolized attractant MeAsp had an average 
value of -0.1 (198). Error bars indicate the standard error of the mean. One-tailed student t-test was 
performed to assess the significance of the response being different from 0 (**: P ≤ 0.05; *: P ≤ 0.1). 
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1.2. Mechanism of hormone sensing 
In order to identify which receptor(s) sense each hormone at different concentrations, and 
how hormones are sensed in general (e.g. by the periplasmic, cytoplasmic or membrane 
perturbation), we performed FRET experiments in strains with different receptor 
backgrounds. Strains expressing only one chemoreceptor, just the cytoplasmic part of the 
receptors, hybrids that combine domains from different receptors, and mutants of Tar with 
changes in the transmembrane region and in the HAMP domain, were analyzed. 
Briefly, the topology of the ligand-binding chemotaxis receptors is composed of a 
transmembrane sensory domain, a signal conversion domain, and a signaling domain that 
interacts with the kinase. The transmembrane sensory domain consists of an extracellular 
sensory domain and two transmembrane regions TM1 and TM2. When ligand binds to the 
pocket inside the sensory domain, it triggers conformational changes in the TM region. This 
conformational signal is further transduced to the cytoplasmic part of the receptor that 
converts the signal, consisting of a HAMP domain. The signaling domain contains a MH 
bundle, a flexible bundle, and a protein contact region that interacts with the kinase and 
regulates its activity. The conventional response to known ligands is mediated by the ligand 
binding to the periplasmic sensory domain (25). 
 
1.2.1. Responses to hormones mediated by an interplay between Tar and Tsr  
Known ligands of E. coli, such as amino acids, are recognized to be mediated by the two 
more abundant chemotaxis receptors Tar and Tsr (21, 51). In order to identify the role of 
these two major receptors in the overall chemotactic response to gut compounds, FRET 
measurements were also performed in strains expressing only one of the chemoreceptors, 
at levels similar to the net endogenous expression in the wild type (Appendix-Figure 6).  
We observed that both Tar and Tsr could mediate responses to the four analyzed 
catecholamines, indicating that chemotaxis of wild-type E. coli results from an interplay 
between Tar- and Tsr-mediated responses. The Tsr-mediated response apparently makes a 
 
 
larger contribution to the behavior of the wild-type cells, consistent with Tsr being the most 
abundant receptor under our growth conditions (15, 209).  
Specifically, Tar mediated an attractant response to dopamine, whereas the Tsr-only strain 
showed the same biphasic trend as the wild type, switching from repellent to attractant 
(Figure 21A, Appendix-Figure 6A, B). For NE, Tar showed an attractant response (Appendix-
Figure 6C), whereas Tsr sensed NE as a repellent over the entire concentration range (Figure 
21B, Appendix-Figure 6D). For DHMA, both Tar and Tsr mediated repellent responses 
(Figure 21C, Appendix-Figure 6E, F). These results suggest that – in contrast to a previous 
report (75) – the NE sensing could not be solely explained by the conversion of NE into 
DHMA, since Tar responses to NE and DHMA were clearly different. 
Additionally, in the case of melatonin, Tar and Tsr mediated a repellent response, similar to 
the response of the wild-type strain (Figure 21D, Appendix-Figure 6G, H). In Tsr-only cells, 
the relative kinase activity change was the strongest. Thus, E. coli sensing melatonin imply, 
as for the catecholamines, an interplay between the major chemoreceptors Tar and Tsr, 
which results in an intermediary response in the wild type cells.  
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Figure 21: Dose responses of wild-type cells (circles), Tar-only cells (squares) or Tsr-only cells (diamonds) to 
dopamine (A), NE (B), DHMA (C) and melatonin (D), performed as in Figure 14. Error bars correspond to the 
standard error of the mean of three independent experiments. 
 
The insulin response for Tsr and Tar-only cells strains showed always an attractant response 
towards insulin. As detected for the remaining hormones, the response of the Tsr-only cells 
was more sensitive than the remaining strains (Figure 22, Appendix-Figure 7A, B). In 
opposition to the previous hormones, the wild type response to insulin cannot be 
accounted by a combination of Tar- and Tsr-mediated responses. However, it remains 
 
 
unknown whether these responses are indirect or mediated by one of the low-abundance 
receptors, Tap or Trg, and more experiments are required.  
 
 
 
Figure 22: Dose responses of wild-type cells (black circles), Tar-only cells (white squares) or Tsr-only cells 
(white diamonds) to insulin, performed as in Figure 14. Error bars correspond to the standard error of the 
mean of three independent experiments.  
 
As performed for the wild type results, the results obtained for the Tar and Tsr-only cells 
were confirmed with the chemotactic drift assay. The observed chemotactic behavior was 
consistent with the FRET responses for the single-receptor strains, as observed for the wild 
type, (Figure 23). The Tsr-only strain showed repellent responses to all tested hormones in 
the 0 to 1 mM gradient, similar to the dominant response observed in this concentration 
range by FRET. In contrast, Tar showed attractant responses to dopamine and NE, but a 
repellent response to DHMA, again consistent with the FRET data. For epinephrine, we 
observed an attractant response for all strains, consistent with a previous report (76). In 
addition, melatonin showed a repellent response in the two strains, consistent with the 
FRET data. Finally, Tar- and Tsr-only strains showed either attractant or no response to 
spermidine, respectively.  
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Figure 23: Chemotactic response in gradients of gut compounds. Chemotactic drift was measured in 
gradients of dopamine, NE, DHMA, Epinephrine (Epi.), Melatonin (Mel.), Spermidine (Sper.) or buffer (∅) 
established in a microfluidic device, performed as in Figure 20. For the positive control, the drift was measured 
in a gradient of 0 to 1 mM aspartate (Asp.) for the wild-type and Tar-only cells or in a gradient of 0 to 1 mM 
serine (S) for Tsr-only cells. One-tailed student t-test was performed to assess the significance of the response 
being different from 0 (**: P ≤ 0.05; *: P ≤ 0.1).  
 
1.2.2. Response to hormones are mainly mediated by the signaling domain 
As previously mentioned the conventional response to known ligands of the chemotaxis 
pathway is mediated by the ligand binding to the periplasmic sensory domain (25). To 
determine if the response to hormones is mediated by the periplasmic sensory domain of 
Tar and Tsr, we used “pinhead” Tar and Tsr constructs that lack the entire periplasmic 
domain, but are nevertheless able to activate the kinase (210).  
Starting with dopamine, Tar-pinhead and Tsr-pinhead strains both mediated responses 
towards dopamine. While below 0.1 mM, the Tar-pinhead strain showed a repellent 
response similar to the Tar strain response, at higher concentrations, dopamine became an 
attractant for the full Tar while remaining repellent to Tar-pinhead. Interestingly the sudden 
shift to attractant observed in the Tsr-only cells could not be reproduced in the Tsr-pinhead 
strain (Figure 24A). These results suggest that the response to dopamine at high 
concentrations may be accounted by the sensory domain of the receptors. 
 
 
The response of Tar and Tsr-pinhead strains followed the same trend as for the Tar and Tsr 
strains for the remaining hormones – NE, DHMA and melatonin. Though the amplitude of 
the response was generally weaker than for the full-length receptors (Figure 24B, C, D), this 
weaker response may be accounted by a different conformation of this strains. 
Interestingly, at 10 mM of NE the response for the pinhead constructs showed a stronger 
response than the full-length receptors (Figure 24B). 
These results suggest that the sensing mechanism of these hormones probably originates in 
the signaling domain, since the responses had overall the same signal. However, for 
dopamine and NE the response at high concentrations may involve a different domain or 
mechanism. For example, at high concentrations the response is likely due to the sensory 
domain, which we did not observe at lower concentrations. 
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Figure 24: Dose responses of strains expressing only Tar (squares) or Tsr (diamonds) to dopamine (A), NE (B), 
DHMA (C), melatonin (D) and spermidine (E), as performed in Figure 14. Responses of strains harboring full-
length receptors are represented with full lines, pinhead construct responses are shown with dashed lines. 
Error bars correspond to the standard error of the mean of three independent experiments. 
 
In order to narrow down the hormones sensing mechanism we also investigated the 
response to catecholamines in hybrid receptors and Tar constructs.  
We first investigated hybrids of Tar, with changes in the transmembrane region or in the 
HAMP domain, TarTM and TarHAMP strain respectively. In the TarTM strain, two amino acids 
were added in the transmembrane region and in the TarHAMP strain, a random linker was 
introduced after the HAMP domain (Figure 25). Both insertions invert the chemicals 
 
 
response when the ligands are sensed upstream of the insertion. The Table 6 displays all 
strains used in this study, as well as the controls response to wild type, Tar- and Tsr-only.  
The studied hybrids combine the sensory domain of one receptor and the signaling domain 
of the other receptor (Figure 25) (28). Thus, the Tasr strain couples the sensory domain of 
Tar with the signaling domain of Tsr. Complementary, the Tsar strain combines the sensory 
domain of Tsr with the signaling domain of Tar. Surprisingly, an attractant response sensed 
by the Tar signaling domain elicits an increase in the kinase activity, which is translated into 
a typical repellent response in this strain. This inversion probably originates from a different 
conformation that appears to change the signal transduction through the receptor. 
  
Table 6: Chemotaxis responses to α-methyl-DL-aspartate (MeAsp) and L-serine of all 
analyzed strains and constructs in this work. 
+: attractant response; -: repellent response; NA: no response or not determined 
Strains MeAsp response Serine response Refs 
WT + + (211) 
Tar + + (211) 
Tsr + + (211) 
Pin-Head Tar + + (28) 
Tsar - + (28) 
Tasr + + (28) 
TarHAMP - + Shuangyu Bi, unpublished data 
TarTM - + Shuangyu Bi, unpublished data 
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Figure 25: Cartoon illustrating Tar-Tsr hybrids (Tsar and Tasr) and Tar constructs (TarHAMP and TarTM). 
Domains of Tar are shown in orange and domains of Tsr in green. In the TarTM strain two amino acids were 
added in the transmembrane region, marked with pink circles and in the TarHAMP strain a random linker was 
introduced after the HAMP domain, marked as a pink string. 
 
First, we identified which part of the Tar receptor is detecting dopamine. The response of 
the TarHAMP construct to 1 mM dopamine was repellent (Figure 26B), which represents an 
inversion compared to Tar, suggesting that the sensing occurs upstream of HAMP. 
Additionally, the response to dopamine was abolished in the TarTM strain. This strongly 
suggests that the sensory domain of Tar is responsible for sensing high concentrations of 
dopamine. This is in agreement with the results obtain for Tar-pinhead. To gain insights into 
the sensing mechanism of dopamine by Tsr, we also analyzed the Tasr strain. The Tasr strain 
showed a repellent response to 1 mM of dopamine (Figure 26G), as the Tsr-only strain and 
Tsr-pinhead did, suggesting that dopamine is sensed by the signaling domain of Tsr, and 
that the resulting receptor conformational change, and associated effect on kinase activity, 
is dominant over the one elicited by dopamine binding to the Tar sensory domain. Contrary 
to the wild type, Tar and Tsr responses at higher concentrations of dopamine (10 mM), we 
observed unspecific fluorescence changed for the mutant receptors, which prevented 
further analysis. Since we speculated that at high concentrations the dopamine sensing may 
have a different mechanism, this unspecific response may suggest that the response at high 
 
 
concentrations may require both functional periplasmic and signaling domains. Overall, Tar 
senses dopamine via its sensory domain, while Tsr signaling domain is affected by the 
hormone. Although extrapolating the results obtained in the hybrid mutants should be done 
with caution, they suggest that the stimulation by dopamine of the signaling domain of Tsr 
elicits a stronger activity change than the stimulation of the sensory domain of Tar (Table 7). 
However, the explanation of the shift observed at 10 mM in the Tsr strains could not be 
explained by these experiments. 
To study if a specific domain is responsible for sensing NE, we first analyzed the response in 
the TarHAMP and TarTM constructs. The response to NE of both strains was repellent from 1 
mM of NE (Figure 26A, D), which is an inversion compared to the response of the full length 
Tar. This implies that NE sensing occurs again upstream of the TM region, contrary to the 
Tar-pinhead response. Nonetheless, the Tasr hybrid strain also elicited a repellent response, 
as the Tsr-only strain response, to NE (Figure 26F). As suggested for dopamine, these results 
imply that the stimulation by NE of the signaling domain of Tsr has a stronger activity than 
the sensory Tar domain (Table 7).  
To identify the domain that elicits the chemotactic response to DHMA, we analyzed the 
response of TarTM and TarHAMP. The response of these constructs to DHMA was repellent 
(Figure 26C, D), as observed for the Tar strain. This suggests a strong role of Tar signaling 
domain in sensing DHMA, supported by the Tar-pinhead response. In order to understand 
the role of Tsr receptor the Tsar hybrid was analyzed. Here, we obtained an attractant 
response (Figure 26H), which represents an inversion compared to Tar and Tsr-only strains 
responses. As mentioned above the Tsar strain elicits an inversion of the signal when the 
origin of the signal is by the signaling domain, which further indicates a role of the Tar 
signaling domain in sensing DHMA (Table 7).  
In conclusion, the signaling domains are dominant in the response to the catecholamines, 
suggesting that this taxis is mediated by effects on the cytosolic part of the receptors (Table 
7). However, at high concentrations, specifically for dopamine, hormones sensing may 
involve the sensory domain in a yet unknown way.  
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Figure 26: Typical chemotactic pathway responses for the hybrids TarHAMP (A, B, C), TarTM (D, E), Tasr (F, G) 
and Tsar (H) to NE, Dopamine and DHMA, performed as in Figure 14. α-methyl-DL-aspartate (MeAsp) and L-
serine were used as controls. 
 
 
Table 7: Response to dopamine, NE and DHMA of strains harboring the listed receptor 
constructs, with domain dominating the response being indicated.  
 WT Tar Tsr Tsar Tasr TarHAMP TarTM Origin of the 
response 
DOPAMINE - + - X - - X 
Tsr signaling 
domain 
NE - + - X - - - 
Tsr signaling 
domain 
DHMA - - - + X - - 
Tar signaling 
domain 
Responses to 1mM of catecholamines. +: attractant response; -: repellent response; X: not determined 
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1.3. Mechanism of the spermidine response  
In contrast to the hormone responses, the wild type response to spermidine could not be 
accounted by a combination of Tar- and Tsr-mediated responses. The single receptor strains 
(Tar and Tsr-only cells) were more sensitive to lower concentrations of spermidine (10-2 mM 
for Tar-only strain and 10-1 for Tsr-only strain) than the wild type strain, although this 
response switched from repellent to attractant with the increase of the concentration 
(Figure 27A, Appendix-Figure 6I, J).  
To determine the role of the periplasmic domain of Tar and Tsr in spermidine sensing, we 
used once more Tar- and Tsr-pinhead constructs that lack the entire periplasmic domain 
(210). The Tsr-pinhead construct had similar responses than the full-length receptor, but 
with a lower relative kinase activity (Figure 27B). On the other hand, the Tar-pinhead strain 
showed a delayed shift from repellent to attractant than the Tar-only strain. The different 
responses between strains harboring full-length receptors and pinhead constructs imply the 
dominant role of the signaling domain in spermidine sensing by Tar and Tsr. Furthermore, 
the single receptors Tar and Tsr showed weaker and biphasic responses, with attractant 
responses at high concentration where the wild type strain showed a clear repellent 
response. We thus hypothesized that the minor receptors probably mediate the response 
to spermidine in wild type E. coli. 
 
 
Figure 27: Dose responses of wild-type cells (black circles), Tar-only cells (white squares) or Tsr-only cells 
(white diamonds) to spermidine (A, B), as performed in Figure 14. Responses of strains harboring full-length 
receptors are represented with full lines, pinhead construct responses are shown with dashed lines. Error bars 
correspond to the standard error of the mean of three independent experiments. 
 
1.3.1. Trg receptor mediates response to spermidine 
As mentioned above, our data implied that the strong repellent response to spermidine, 
observed in wild type, appears to be mediated by one of the low-abundance receptors, Tap 
or Trg. Since neither Trg nor Tap can mediate chemotactic response as the sole receptor 
(29), we investigated the response of trg and tap deletions strains to determine the 
receptor specificity (Figure 28A).  
Whereas ∆tap strain responded to spermidine similarly to wild type, the response of ∆trg 
strain was comparable to the one observed for Tar- and Tsr-only strains (Figure 28A, 
Appendix-Figure 8A). This clearly implies that Trg is mediating the wild type repellent 
response to spermidine. To further confirm the involvement of the Trg receptor in 
spermidine sensing, wild-type cells were adapted to a saturating concentration of ribose 
(Trg-specific attractant), before stimulation with spermidine (Appendix-Figure 8B). 
Adaptation to ribose indeed abolished the repellent response to spermidine, implying that 
the interaction of the periplasmic ribose-binding protein (RBP), with the sensory domain of 
Trg, which is known to mediate response to ribose (212, 213), interferes with the 
spermidine sensing.   
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1.3.2. Response to spermidine requires periplasmic BP PotD  
Signaling via periplasmic binding proteins (BPs) is common not only to ribose but to all Trg- 
or Tap-specific chemoattractants for which the sensing mechanisms have been established. 
These periplasmic BPs are components of the ATP binding cassette (ABC) transporters, but 
they also interact with the low-abundance receptors and regulate their activity upon 
binding their ligands.  
We thus hypothesized that the preferential E. coli ABC transporter for spermidine, PotABCD 
(162, 163), might be involved in Trg-mediated response.  
The PotABCD transporter complex is composed of PotD, the periplasmic BP, PotA, the 
membrane-associated ATPase, and PotB and PotC, two membrane-spanning components of 
the transmembrane channel (162, 214). Notably, the crystal structure of the PotD protein 
complex with spermidine is very similar to E. coli D-Glucose/D-Galactose-binding protein 
(GBP) (215), another interaction partner of Trg. 
We indeed observed that the deletion of potD abolished the specific repellent response to 
spermidine, thus having a similar effect as the trg deletion (Figure 28B, Appendix-Figure 8C). 
The attractant response was restored when potD was complemented by expression of 
plasmid-encoded PotD (Appendix-Figure 8D). On the other hand, the deletion of the 
membrane-associated ATPase potA showed a repellent response that was similar to that of 
the wild-type strain (Figure 28B). These data suggest that the interaction of the periplasmic 
BP PotD with Trg indeed mediates E. coli repellent response to spermidine.    
 
 
 
 
Figure 28: Dose responses to spermidine for (A) ∆trg cells (red crosses) and ∆tap cells (black crosses) and (B) 
∆potD (white triangles), ∆potA (white diamonds), and ∆potD/potD+ (grey triangles) cells (see Appendix-
Figure 5). Differences between ∆trg and ∆tap responses in (A) and between ∆potD and ∆potA or ∆potD/potD+ 
responses (B) are significant according to student t-test performed at 10 mM spermidine (P ≤ 0.01). 
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2. Physiological importance 
2.1. Effects of the gut compounds on E. coli growth  
To understand the physiological relevance of the observed chemotactic responses, we 
analyzed the effects of the compounds on growth of a planktonic E. coli MG1655 culture. 
Consistent with previous observations showing that some hormones influence bacterial 
growth (94, 132, 164), we detected effects of several compounds. In order to have 
comparable results and since the different tested compounds influence different stages of 
growth, we calculated the area below the curve of each experiment as a measure of time 
average OD (see Material and Methods, Appendix-Figure 9).  
Among those, dopamine, L-DOPA and epinephrine enhanced E. coli growth, with the effect 
of dopamine being the most pronounced (Figure 29, Appendix-Figure 10), in agreement 
with previous reports (93, 164). As dopamine develops a black color during incubation, 
possibly due to its oxidation, we always subtracted a baseline calculated using growth 
medium with dopamine where no cells were inoculated. Additionally, we confirmed this 
result directly by performing colony-forming units counting assay were a higher number of 
viable cells in the cultures with dopamine was indeed determined (Figure 30). Although the 
exact mechanism of this growth stimulation remains to be investigated and will be 
discussed in a later chapter, it has been suggested that the effect may be due to the 
dopamine-mediated enhancement of iron uptake by E. coli (132, 164). 
In contrast, DHMA and melatonin were growth-inhibitory, and even stronger growth 
inhibition was observed for spermidine. Interestingly, the effect of spermidine was only 
detected at 1 mM and above, whereas lower concentrations did not produce any significant 
effect (Figure 29). This decrease in the growth of E. coli with high concentrations of 
spermidine was previously observed and accounted by regulation of specific proteins, many 
of which are related to response to stress by basic pH (216). This range of concentration 
matches the range of chemorepellent response observed in this study. 
 
 
 
 
 
Figure 29: Effect of the gut compounds on E. coli growth. E. coli strain MG1655 was grown at 37°C in TB 
media containing the indicated compounds at a final concentration of 1 mM. Optical density of the culture 
was measured at 600 nm as described in Materials and Methods and the time-averaged OD was calculated as 
the area below the curve divided by the duration of the experiment. For each experiment, the time average 
OD was normalized to the time-average OD of the control culture in TB (red dashed line). Grey bars represent 
the catecholamine group; black bars the thyroid group; and white the polyamine group. One-tailed student t-
test was performed against the control (**: p≤0.01; *: p≤0.05). Each bar represents the mean of at least three 
independent experiments, with error bars indicating standard deviation. 
 
Addition of serotonin, putrescine and NE had no significant effect on growth at the tested 
concentration. 
The same results for growth were obtained in the two tested minimal media (Appendix-
Figure 11), M9 and SAPI, a minimal salts medium supplemented with 30% (v/v) adult bovine 
serum that exposes bacteria to conditions environmentally similar to most mammalian 
tissue, such as iron limitation, limited nutrient availability, and immune defense proteins 
such as antibodies (93).  
Thus, except for NE and dopamine – which showed a biphasic response in FRET - the 
chemotactic response towards the tested compounds correlates with the observed growth 
effect, strongly suggesting that the observed chemotactic responses to gut compounds are 
indeed physiologically significant (Table 8).  
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Figure 30: Effect of dopamine on the number of colony forming units (CFU) of E. coli cultures. CFU count was 
determined on LB plates for the culture grown at 37°C in TB with indicated dopamine concentrations as 
described in Material and Methods. Experiments were performed in triplicates. The CFU/ml is the number of 
colonies per volume of inoculation. Error bars indicate standard deviation. 
 
Table 8: Effect of gut compounds on chemotaxis and growth in E. coli 
 
ND: not determined; 0: no response/effect; +: attractant/enhancement; -: repellent/inhibition 
aResponse of the wild-type cells. 
*, **, *** One-tailed student t-test statistical significance to the control of P ≤ 0.1, P ≤ 0.05 and P ≤0.01, 
respectively (based on Figure 20 and Figure 29)  
 
 
 
2.2. Effects of the gut compounds on pathogenic bacteria 
Recent work suggested that hormones trigger expression of virulence genes, therefore we 
analyzed the effect of hormones on pathogenic bacteria, which share the same natural 
environment as E. coli K-12 (217, 218). To this end, we evaluated the effect of hormones on 
the growth of E. coli EcoR64 and Salmonella enterica serovar typhimurium ATCC 14028.  
All three strains E. coli MG1655, EcoR64 and S. typhimurium displayed a similar growth rate 
for all the tested compounds. However, in contrast to E. coli MG1655, where the addition of 
dopamine had approximately a 2-fold increase in the maximal OD, the growth in 
S. typhimurium was significantly reduced (Figure 31A, B). Interestingly, oxidation of 
dopamine, resulting in a darker color of the media, has not been observed. These results 
suggest that Salmonella may uptake and degrade dopamine. Still, the exact mechanism 
remains to be unraveled.  
 
 
Figure 31: Effect of different concentrations of dopamine on S. typhimurium (A) and E. coli MG1655 (B). 
Cultures were grown at 37°C in TB media containing the indicated final concentrations of dopamine. Optical 
density of the culture was measured at 600 nm as described in Materials and Methods.  
 
2.3. Hormones influence gene expression 
In order to have a holistic picture and to understand how the addition of gut compounds 
can influence bacterial growth we performed RNA-sequencing (or RNA-seq). This technique 
Results 
  
 
Page | 99  
  
evaluates the changes in the cellular transcriptome and could help us understand the 
mechanism of hormone sensing, on a system level. We focused on the compounds that 
produced a stronger effect on E. coli growth, dopamine, melatonin and spermidine.  
The Figure 32 scatter plots show the pattern of gene expression changes in the MG1655 
strain upon addition of 1 mM of melatonin, dopamine and DHMA. Genes whit more than 3-
fold changes in the presence of the respective compounds are summarized in Table 9 (see 
complete table in Appendix-Table 1). These genes are good candidates to explore the 
influence of the compounds on growth. 
In more detail, Figure 32A, B, C shows the gene expression pattern upon stimulation with 
dopamine, melatonin and DHMA, respectively. Interesting candidates are highlighted in the 
individual figures. The downregulated genes fecB, fecA and tdcD belong to two operons – 
fec and tdc (Figure 32A). fecB and fecA encode for a ferric citrate periplasmic binding 
protein and a ferric citrate extracellular receptor of the ABC ferric citrate transporter 
system, respectively (219). These genes belong to the class of iron transporters and 
together with the previous findings that the catechol ring in dopamine may behave as a 
siderophore ring, which improves the iron uptake in Gram-negative bacteria (164, 220), 
they may be relevant for the mechanism of catecholamines sensing and transport. The tdc 
operon encodes a pathway for the transport and anaerobic degradation of L-threonine to 
propionate (221). The trpE gene was upregulated with the dopamine stimuli, remarkably 
the trp operon encodes for the L-tryptophan pathway that is the precursor of the thyroid 
hormones (222). The correlation between the change in the gene expression of the last two 
genes and the effect of dopamine is difficult to grasp, however the fec operon suggests a 
connection between dopamine and iron uptake. We speculate that dopamine may reduce 
Fe3+ to Fe2+, which then could be taken up by bacteria by either ferric (siderophore based) 
or ferrous iron uptake systems, since previous results propose that catecholamines can bind 
inorganic Fe(III) salts (223, 224). 
For the two remaining experiments, finding candidates that might give us a clue on the 
effect of DHMA and melatonin in E. coli, was more complicate. Upon stimuli with DHMA the 
gene ybiJ was upregulated. YbiJ is a putative protein suggested to have a potential function 
 
 
in iron acquisition (225), which may imply also a role in iron uptake, as for dopamine. The 
change in gene expression of yhaK, which encodes for a redox-sensitive bicupin (226), and 
rrsH and rrsC that encode for ribosomal RNA, along with rrlD with DHMA and melatonin 
stimuli remain to be elucidated and may just derive from noise inherent to the technique. 
 
Table 9: Genes with more than 3-fold changes between the control and incubation with 
DHMA, dopamine or melatonin  
 Gene Fold change Gene description NCBI 
DH
M
A 
ybiJ 4.978 up DUF1471 family putative periplasmic protein  
rrsH 4.487 up 16S ribosomal RNA of rrnH operon 
rrsC 4.063 up 16S ribosomal RNA of rrnH operon 
yhak 3.18 up Redox-sensitive bicupin 
DO
PA
M
IN
E 
trpE 7.084 up Component I of anthranilate synthase 
tdcD 4.752 down propionate kinase/acetate kinase C 
fecB 5.072 down Ferric citrate ABC transporter periplasmic binding protein 
fecA 4.957 down Ferric citrate extracellular receptor 
fecE 4.872 down Ferric citrate ABC transporter permease  
fecC 4.628 down  Ferric citrate ABC transporter permease 
fecD 4.416 down Ferric citrate ABC transporter permease 
M
EL
AT
O
N
IN
 
rrsH 4.486 up 16S ribosomal RNA of rrnH operon 
rrsC 4.063 up 16S ribosomal RNA of rrnH operon 
rrlH 3.686 up 23S ribosomal RNA of rrnH operon 
rrlA 3.626 up 23S ribosomal RNA of rrnH operon 
rrsD 3.593 up 16S ribosomal RNA of rrnD operon 
rrsA 3.573 up 16S ribosomal RNA of rrnD operon 
rrlC 3.52 up 23S ribosomal RNA of rrnC operon 
rrlD 3.24 up 23S ribosomal RNA of rrnD operon 
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Figure 32: Changes in gene expression in MG1655 after addition of dopamine (A), melatonin (B) and DHMA 
(C) stimuli. Displayed are scatter plots where each dot is the expression level, in logarithmic scale, of a gene in 
media, comparing before and after the addition of dopamine, melatonin and DHMA. Genes falling on the 
dotted line have equal expression in both media. Genes falling above (respectively, below) the upper (lower) 
line experience a more than 3-fold up-(down-)regulation of the expression upon addition of the compound in 
the medium. 
 
2.4. Dopamine growth effect 
Our data indicated that dopamine might function as a siderophore improving the iron 
uptake and, thus enhancing growth in E. coli, as previously suggested (132, 164). In order to 
exclude any influence of additional metals on growth we used glycerol-salts medium (227), 
which is depleted of trace metals. Under these conditions the enhancement of growth upon 
dopamine addition was less pronounced and observed already at lowest levels of dopamine 
(Figure 33A).  
Furthermore, we compared the influence of dopamine to that of a known siderophore, 
ferrichrome. We compared the growth of cultures where dopamine or ferrichrome were 
added to TB medium at the same concentration. We found that dopamine and ferrichrome 
effects on E. coli cells growth were similar (Figure 33B), what may suggest that these 
compounds have a similar mode of action. As a control, a deletion strain in fhuA was used. 
FhuA is the transporter for ferrichrome and therefore no significant growth inhibition was 
observed.  
 
 
Figure 33: Growth curves wih E. coli MG1655 supplemented with different concentrations of dopamine (A), and 
ferrichrome (B) and EDTA (C). As a negative control ∆fhuA (B) strain was analyzed. Cultures were grown at 37°C in 
glycerol-salt medium (A) and TB media (B and C). Dopamine was added after 3 h of incubation indicated by the 
green arrow (A). Optical density of the culture was measured at 600 nm as described in Materials and Methods. 
We also decided to test a chelating agent to limit the free iron in the media, possibly 
preventing it from binding to dopamine. Therefore, to sequester the iron ions the chelating 
agent EDTA was also added to the cultures with dopamine (Figure 33C). The E. coli growth 
was delayed in the presence of EDTA, although the cells reached the same final OD after 14 
h of incubation. Probably the concentration of EDTA has to be increased in order to 
completely block the dopamine effect. These results suggest that dopamine might have a 
siderophore-like effect, although if its exact role in promoting iron uptake and thereby cell 
growth remains to be elucidated.  
Additionally, we performed liquid chromatography tandem-mass spectrometry (LC-MS/MS) 
assay, in order to determine if dopamine degrades after incubation, and no degradation 
was detected (data not shown).  
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Additionally, we aimed to unravel the transport mechanism of dopamine, as implied by the 
RNA-seq data, where we observed a downregulation of the ferric citrate transporters. We 
speculated that some other receptors for iron uptake might also play a role for dopamine 
uptake. We performed growth experiments with deletion strains of the eight known iron 
transporters in E. coli: fepA, fiu, cir, fhuA, fhuF, fhuE, lutA and fecA, in the presence and 
absence of 1 mM dopamine. Furthermore, we also analyzed the growth of the deletion 
strain fur, the ferric uptake regulator of E. coli (Figure 34A). We expected that strains 
deleted for a putative dopamine transporter would not show any growth effect. The final 
OD was normalized to the OD in cultures were no dopamine was supplemented (Appendix-
Figure 12). Interestingly, none of the strains showed a reduction in growth compared to the 
control strain, MG1655 (Figure 34B). The ∆fiu strain even had an increase in the relative 
final OD. Thus, our results suggest demonstrate that dopamine is transported by a 
combination of transporters or via a different mechanism.  
Additionally, it was also previously proposed that NE and epinephrine are sensed by QseBC, 
a two-component regulatory system, which is also involved in the regulation of flagella and 
motility by quorum sensing in E. coli (130, 133, 228). However, these data could not be 
corroborated by real-time qPCR, where no significant increase was observed in qseC or qseB 
gene expression level upon addition of either NE and dopamine (Appendix-Figure 13).  
 
 
 
Figure 34: Components of iron transport in E. coli growth (A; see Figure 9). Growth effect on transporter 
deletion strains upon addition of 1 mM of dopamine in E. coli MG1655 (B). Cells were grown at 37°C in TB 
media with and without 1 mM of dopamine. Optical density of the culture was measured at 600 nm as 
described in Materials and Methods and the relative OD was calculated by normalization to the cultures with 
no dopamine supplemented. Values of relative final OD higher than 1 represent an enhancement in final OD 
when compared to no addition of dopamine, conversely values lower than 1 represent a comparative 
reduction in the final OD. Each bar represents the mean of at least three independent experiments, with error 
bars indicating standard deviation. 
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DISCUSSION 
Microbial endocrinology is an interdisciplinary research field that represents the 
intersection of microbiology, endocrinology and neurophysiology. Its main objective is to 
understand the ability of microorganisms to interact with a host under various physical and 
behavioral conditions, both in healthy hosts and during disease. 
While most of the microbial endocrinology studies have focused on how different bacterial 
species change the concentrations of hormones in the GI tract, less attention has been paid 
to the reaction of the microbes themselves to these compounds (88, 94, 109). In this study, 
we used Escherichia coli as the model enteric bacterium to investigate chemotactic 
responses to a range of compounds that are present in the human gut. We focused our 
analysis on the following compounds: the catecholamines L-tyrosine, L-DOPA, dopamine, 
norepinephrine (NE), epinephrine and DHMA; the thyroid hormones serotonin and 
melatonin; the sex hormones estradiol and testosterone; insulin and the polyamines 
putrescine and spermidine (Table 10). 
Table 10: Summary of obtained chemotactic response to the tested gut compounds 
 Compounds Chemotactic responses in Wild Typea 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ND: Not detected; a: results of FRET experiments 
1. Chemotactic responses correlate with the compound availability in the gut 
Although measurements of the accurate concentration across the gut are complicate by the 
heterogeneity of the gut environment and strong dependence on food content and health 
state of the host (229-231), it is believed that the analyzed compounds accumulate in the GI 
tract at different rates. For instance, the catecholamines, L-tyrosine and L-DOPA are 
thought to not accumulate at high concentrations in the lumen of the gut. L-tyrosine has 
been shown to be taken up by the blood and concentrated within the brain and other 
catecholamine-synthesizing tissues (232-234), while L-DOPA is described to be rapidly 
converted to dopamine and the remaining absorbed mainly in the small intestine (128, 200, 
235). Other compounds such as the polyamine putrescine are also believed to be rapidly 
converted into spermidine and spermine (205). 
Remarkably, we observed chemotactic responses to the majority of the compounds that are 
known to accumulate in detectable concentrations in the gut, namely dopamine, NE, 
melatonin and spermidine (127, 141, 236-238). These compounds can reach micro- to 
millimolar levels across the gut lumen (127, 205, 239) and even higher concentrations are 
expected to be present in the vicinity of the mucous layer where these compounds are 
Catecholamines 
L-tyrosine ND 
L-DOPA ND 
Dopamine Biphasic  Repellent / Attractant 
Norepinephrine Biphasic  Attractant / Repellent 
Epinephrine Attractant b 
DHMA Repellent 
Thyroid 
hormones 
L-tryptophan ND(190) 
Serotonin ND 
Melatonin Repellent 
Sex hormones Estradiol ND Testosterone Repellent 
Peptide Insulin Biphasic  Attractant / Repellent 
Polyamines Putrescine ND Spermidine Repellent 
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secreted, consistent with the observed range of concentrations eliciting a chemotactic 
response. These responses seem to be physiologically relevant, considering that no 
response could be detected for their precursors with similar chemical structure (L-tyrosine, 
L-tryptophan, L-DOPA and putrescine). These compounds are primarily derived from food 
sources and are rapidly turned over in the GI tract (205, 240), and are therefore unlikely to 
form long-lived gradients that can be used for orientation in the intestine. Our results thus 
provide further evidence for the hypothesis that bacteria can specifically utilize host signals 
to detect their GI location, as previously suggested (75-78, 130, 241, 242). 
In contrast, some exceptions were found in our results, namely for serotonin and 
epinephrine. Unexpectedly, we observed no significant chemotactic response for serotonin, 
although it has been estimated that approximately 95% of serotonin is found in the GI tract 
(202, 203), and it has been described to activate Pseudomonas virulence in vivo, within the 
intestines of mice (243). Since we did not observe any chemotactic response to serotonin, 
we speculate that this hormone may only affect pathogenic bacteria, or be a useful cue only 
for some bacteria. On the other hand, epinephrine elicited an attractant response in our 
experiments, consistent with a previous report (76). Nonetheless, this compound is believed 
to be present in the GI tract at lower concentrations than NE and dopamine, since the 
enzyme required for its synthesis from NE is not expressed in the intestinal mucosa (79). 
Interestingly, previous studies that correlate the effect of epinephrine with the regulation of 
virulence genes in bacteria have revealed a clear preference for NE and dopamine over 
epinephrine (76, 242). Therefore, despite epinephrine elicited a strong attractant response 
in E. coli, it is possible that in the gut natural environment NE and dopamine chemotactic 
responses would overcome the epinephrine response.  
We also detected chemotactic responses to other hormones, insulin and testosterone, that 
have been described to accumulate in the gut, even if their role in microbial endocrinology 
has been less studied to date. Insulin has been described to influence significantly the 
microbiome composition in diabetic patients (151, 152). Despite the measurement being 
technically difficult, we observed a biphasic chemotactic response to insulin, changing from 
attractant to repellent when concentration increases. We conclude that the attractant 
 
 
response is, however, not specific and comes possibly from insulin degradation to individual 
amino acids.  
Examples of bacteria affected by sex hormones have been reported since the 1980s (147-
149). In our study, a chemotactic repellent response was detected to testosterone and no 
response was elicited by estradiol. These hormones may elicit different responses in E. coli, 
since their range of concentration in the GI lumen is not the same. Bacteria may have 
adjusted to changes in concentration of testosterone, because this hormone was described 
to vary its concentration in the gut (244), while estradiol presents more stable 
concentrations. Sex hormones were also involved in the development of obesity and 
metabolic disorders, however the interrelationship between the balance of sex hormones 
and metabolism is complex, and the underlying mechanisms are still unclear. 
In conclusion, our results provide evidence for the hypothesis that bacteria can utilize 
eukaryotic signals to detect their GI location (76, 130).  
 
2. Hormone sensing mechanism - interplay between Tar and Tsr  
With the exception of epinephrine, all the analyzed hormones produced a repellent or 
biphasic response and the wild type chemotactic response appears to be the result of an 
interplay between the responses mediated by the two major E. coli chemoreceptors, Tar 
and Tsr. For almost all the hormones, the Tsr-mediated response seem to make a larger 
contribution to the behavior of the wild-type cells, consistent with Tsr being the most 
abundant receptor under our growth conditions (15, 209). Such interplay between Tar- and 
Tsr-mediated responses is similar to the previously characterized tactic behavior in 
gradients of pH and temperature (28, 61), but contrasts with the responses to conventional 
chemoattractants that specifically bind to the periplasmic sensory domains of the receptors. 
In those cases, ligands are sensed through the periplasmic sensory domains of receptors 
and typically possess high receptor specificity. The strongest effect of the Tsr 
chemoreceptor was especially prominent in the compounds sensed biphasically, dopamine 
and NE, where the Tsr response also inverted when concentration changed and determined 
the wild-type response.  
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Although the exact molecular mechanism(s) of the cytoplasmic sensing remains to be 
elucidated, it nevertheless appears to be specific, since chemically closely related precursor 
compounds elicited no response.  
 
2.1. Repellent response to hormones 
Typical repellents are potentially toxic chemicals that could harm the cells, such as high 
concentrations of heavy metal ions Ni2+and Cu2+, which form nonspecific complexes in the 
cell (53). Usually, attractant binds directly to the receptor’s ligand-binding site or indirectly 
via the help of a periplasmic binding protein. It has been suggested that sensing of 
repellents by Tar is different from its sensing of attractants (59). Another possibility for 
sensing of repellent is through their effect on the properties of the membrane, as the 
membrane fluidity. However, it has been shown for most of the repellents that the sensing 
is not mediated by their general effect on the membrane fluidity (245). A non-classical 
sensing mechanism was recently proposed for phenol sensing by Tsr, in which phenol elicits 
a signaling response by diffusing into the cytoplasmic membrane and influencing the 
stability of the transmembrane helices thereby producing a conformational change in the 
HAMP domain that mimics the binding of ligand (246). Glycerol and ethylene were 
suggested to act through a similar mechanism as phenol (247). It was also demonstrated 
that repellent stimuli, as glycerol, indole, and L-leucine, are not sensed by the periplasmic 
domain (245). 
In this study, we examined the chemotactic repellent response to DHMA. A chemotactic 
response towards DHMA had already been found in a previous study by Pasupuleti et al. 
(75). Since the response was only observed when the cells were incubated with NE, it was 
proposed that in E. coli the response to NE is due to its conversion to DHMA. A strong 
attractant response was observed to DHMA in that study, which decreased amplitude with 
the increase of concentration until 50 µM, where the response ceased (75). As previously 
mentioned in our study, we detect a weak attractant response until 50 µM, where the 
response sifts to repellent. Additionally, strains lacking the Tsr receptor did not elicit a 
response to DHMA in the referred study. Therefore, it was concluded that an intact serine-
 
 
binding site is required for sensing DHMA (75). Our analysis revealed an attractant response 
for NE in Tar-only strain, whereas Tsr sensed NE as a repellent over the entire concentration 
range. Additionally, for DHMA both Tar and Tsr mediated repellent responses. Our results 
suggest that the NE sensing at high concentrations could not be solely explained by its 
conversion into DHMA, since Tar responses to NE and DHMA were clearly different. The 
difference between results may be due to the different methods utilized. These 
experiments were done in a microfluidics assay, which requires an incubation period before 
the measurement (of at least 20 minutes) to acquire the concentration gradient (75). This 
incubation period may lead to a decrease in the response because the compounds may be 
taken up, similar to what we observed in our microfluidics experiments. Further 
investigations on the mechanism of the repellent response to DHMA were performed in the 
current report. The Tar constructs TarTM and TarHAMP with changes in the transmembrane 
region and the HAMP domain respectively, showed repellent responses to DHMA, as for the 
Tar strain. These responses suggest a dominant role of Tar signaling domain. Furthermore, 
the Tsar hybrid response to DHMA, that combines the Tsr sensory domain and the Tar 
signaling domain, was also mediated by the Tar signaling domain. In conclusion, it appears 
that the Tar signaling domain is dominant in the response to the DHMA. Repellent sensing 
by the cytoplasmic signaling domain of receptor has been previously shown for responses 
to the changes of cytoplasmic pH (248).  
 
2.2. Biphasic response to hormones 
Chemotactic signaling in E. coli involves transmission of both attractive and repulsive 
stimuli. Biphasic chemotaxis to some compounds – where the responses are repellent or 
attractant depending on the concentration range - have been described before, for example 
for L-leucine (249), or pH (60). For example, wild-type E. coli bacteria were described to be 
attracted to leucine at concentration between 5 to 120 µM, but repelled from 
concentrations over 0.5 mM. While NE elicited such an attractant-to-repellent biphasic 
chemotactic response, we observed for the chemotactic response of E. coli to dopamine an 
inversion for a repellent response to an attractant when the concentration increased.  
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Biphasic taxis towards chemicals were so far observed to rely on the counteraction of two 
receptors with opposite responses to the compound, the strengths of which are modulated 
when concentration changes. For example, protons are sensed by Tar as attractant and by 
Tsr as repellent (60), similarly to the mechanism of L-leucine sensing (249). While NE was 
also an attractant for Tar and a repellent for Tsr, the situation was extremely 
unconventional in the case of dopamine, since both Tsr and Tar switched from sensing it as 
repellent to attractant as concentration increased. For both compounds, Tsr response had 
the highest weight in the global response of the wild-type cells, in line with its higher 
abundance in our growth conditions. 
To rationalize our results at the level of single receptors, we examined the mechanism of 
chemotactic sensing of dopamine and NE by the receptors. The repellent response of the 
TarHAMP construct to 1 mM dopamine, means an inversion compared to Tar, suggesting that 
the attractant sensing at high concentration occurs upstream of HAMP. Additionally, the 
response to dopamine was abolished in the TarTM strain. This strongly suggests that the 
sensory domain of Tar is responsible for attractant sensing of high concentrations of 
dopamine. Tar-pinhead sensed dopamine at all concentrations, suggesting that the 
cytoplasmic part of the receptor is responsible for the low concentration repellent response 
of Tar, which then is overcome by the sensory domain response at high concentration. On 
the other hand, the Tasr strain that combines the Tar sensory domain with the Tsr signaling 
domain, showed a repellent response to 1 mM of dopamine, as the Tsr-only strain. This 
suggests that dopamine is sensed as a repellent by the signaling domain of Tsr up to a 
concentration of 1 mM – as also supported by the repellent response of Tsr-pinhead, and 
that the resulting receptor conformational change, and associated effect on kinase activity, 
is dominant over the one elicited by dopamine binding to the Tar sensory domain. Overall, 
Tar senses dopamine via its sensory domain, while Tsr signaling domain is affected by the 
hormone (Figure 35). Although extrapolating the results obtained in the hybrid mutants 
should be done with caution, it seems that the stimulation by dopamine of the signaling 
domain of Tsr elicits a stronger activity change than the stimulation of the sensory domain 
of Tar.  
 
 
The response to NE of TarHAMP and TarTM was repellent, which implies that NE sensing 
appears to be upstream of the TM domain of Tar. These results support the role of the 
sensory domain of Tar in sensing NE. Additionally, the Tasr hybrid elicited a repellent 
response to NE, as did Tsr. Combined with the repellent response of Tsr-pinhead, these 
results imply that NE is sensed by Tsr, primarily via its signaling domain, and that the 
stimulation by NE of the signaling domain of Tsr induces a stronger activity change than that 
of the sensory Tar domain (Figure 35).  
In conclusion, the biphasic sensing mechanism to NE seems to be a typical interplay 
between the Tar and Tsr receptor, where the Tsr signaling domain plays a stronger role.  
 
Figure 35: Schematic drawing of the biphasic sensing mechanism to NE and dopamine of Tar and Tsr. High 
and low concentrations of dopamine ([dopamine]) are sensed by different parts of the Tar receptor. Bigger 
arrows highlight stronger role of the Tsr signaling domain. Green labelling represents an attractant response, 
while red labelling represents a repellent response. 
 
3. Repellent response to spermidine mediated by Trg/PotD 
Although the mechanism of hormone sensing by E. coli chemoreceptors remains to be 
investigated, we could show that spermidine is specifically sensed as a repellent by the 
minor receptor Trg. So far, Trg has been only implicated in attractant responses to ribose, 
glucose and galactose, mediated by the interactions of its sensory domain with a 
periplasmic binding proteins, RBP (for ribose) and GBP (for glucose and galactose). Our 
results suggest that the response to spermidine similarly involves the periplasmic binding 
protein PotD, which is part of the spermidine uptake system PotABCD. To our knowledge, 
this is the first example of a repellent response mediated by a minor chemoreceptor. It is 
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also the first example of a repellent response involving a periplasmic binding protein – 
although nickel binding protein has been initially implicated in the repellent response 
mediated by Tar (250), this finding was subsequently disproved (251). 
 
 
 
 
 
 
 
 
 
 
 
 
4. Correlation between chemotactic response and growth effects 
E. coli chemotaxis towards amino acids has been shown to correlate with their order of 
utilization and effect during growth (190). In the gut, E. coli is exposed to amino acid 
gradients of varying composition and it benefits from being able to follow gradients with 
the highest metabolic value (190).  
The effects of hormones on bacterial growth have been previously described extensively 
(132, 147, 164, 218, 220, 223, 242, 252). Here we analyzed the chemotactic preferences of 
the studied gut compounds in relation to their growth effects. In summary, chemotactic 
responses correlated with the growth effects of individual compounds. Although this 
relation was less clear for hormones that elicited biphasic responses, such as dopamine and 
NE, high concentrations of dopamine led to a strong attractant response that was 
consistent with the growth-promoting effect of dopamine. In contrast, for NE both the 
 
 
effect on growth and chemotactic responses were very weak. Low concentrations of 
dopamine and high concentrations of NE, however elicited responses unrelated or opposite 
to growth effects. 
For the compounds that elicited a repellent response, namely DHMA, melatonin and 
spermidine, there was a pronounced correlation with growth inhibition. Although low 
concentrations of DHMA were previously shown to elicit a highly sensitive attractant 
response (75, 77, 78), at high concentrations of DHMA, which affected growth, the behavior 
of E. coli in gradients was apparently dominated by the repellent response. The repellent 
response to melatonin and the observed growth inhibition are consistent with recently 
proposed effects of this hormone on the microbiome, as discussed later (144, 253). As 
previously discussed, serotonin affected neither growth nor chemotaxis of E. coli.  
The only compound that elicited a straight attractant response in the wild-type cells was 
epinephrine, consistent with a previous study (76) and correlating again with its growth-
promoting effect for E. coli. 
 
4.1. NE might behave as a signaling compound 
During homeostasis NE is probably the predominant signal in the intestine (134). It is known 
that this hormone acts in the GI tract and has receptors in the epithelium walls and that its 
activity change with their concentration (237). In stress situations, for example, the 
concentration of NE in the lumen gut increases and NE binds to the β adrenoceptors and A2 
adenosine receptors. This leads to an increase in the cAMP levels and an increase of the 
permeability of the intestinal epithelium, which allows antigens to penetrate through the 
epithelium and thus activating the immune response (237, 254).  
One theory proposes that NE works as signaling molecule for bacterial pathogens to aid 
towards their successful adaptation and survival within the host (93, 94, 134), since its 
concentration in the gut increases in stress situations, leading to the activation of the 
immune response (237, 254). We hypothesize that the biphasic chemotactic response 
observed may have evolved to sense the different concentrations of NE, in order to detect 
the host physiology. In this way, E. coli senses NE when its concentration reaches a certain 
threshold switching the chemotactic response to repellent, in order to predict and escape 
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the subsequent immune response. This may be the reason why at higher concentrations NE 
is repellent, since E. coli may have evolved to “run away” from the epithelium when there is 
an immune response and towards the epithelium when the concentration of NE is lower 
(Figure 36). It is therefore not surprising that mammals appear to have evolved protective 
mechanisms to tightly regulate levels of gut catecholamines and that catecholamine-
degrading enzymes are present throughout the entire length of the human gastrointestinal 
tract (255). 
 
 
Figure 36: Model of the NE signaling between host and microbiota. NE is released into the gut lumen and 
sensed by bacterial receptors and by the host adrenoceptors. Activation of α2AR increases the cAMP levels 
that leads to increase of the permeability of the intestinal epithelium, which allows antigens to penetrate 
through the epithelium and thus activate the immune response. α2AR- α2 adrenergic receptor 
 
4.2. Melatonin modulates the microbiome 
Melatonin is a critical player of the host circadian mechanism and in the homeostasis 
maintenance of the GI tract (142, 143). The emerging role of the gut microbiome as an 
important modulator of gastrointestinal function has recently included the role of circadian 
rhythms. Several studies support the idea of an interaction between melatonin and the 
 
 
microbiome (144, 145, 253) and suggest that microbial signaling plays a critical role in 
homeostatic maintenance of intestinal function along with the host circadian mechanism 
(142, 143). Further studies have expanded this view and have shown that disruption of the 
circadian clock, either via dietary restriction or time shifting affects temporal distribution of 
the gut microbiome constituents (144, 256). While it is clear from some studies that 
commensal bacteria and gut tissues do communicate, it is not clear which signal or signals 
the microbiome exploits to sustain its own homeostasis. 
We suggest that melatonin can be disadvantageous to commensal bacteria, as supported by 
our results where we obtained a repellent chemotactic response and inhibition in growth, 
but simultaneously beneficial for pathogenic bacteria, as suggested for Enterobacter 
aerogenes (145), and hence modulating the microbiome composition. 
 
4.3. Dopamine growth effect 
Until now, the only explanation for the strong effect of the catecholamines (in our case 
dopamine) on the growth of bacteria relates to the iron restriction imposed by a majority of 
host tissues for the growth of most microbial pathogens. A strategy that bacteria often 
employ to scavenge nutritionally essential iron is the production and utilization of 
siderophores, which are secreted low molecular weight catecholate or hydroxamate 
molecules that possess high affinity for ferric iron (257). It has been described that the same 
catechol ring found in many siderophores is also present in the catecholamines (220). 
Freestone et al. shown that NE, epinephrine and dopamine, various inotropes (isoprenaline, 
dobutamine), and a few metabolites (DHMA and dihydroxyphenylglycol) all share the ability 
to facilitate bacterial acquisition of normally inaccessible transferrin and lactoferrin bound 
iron (95, 132, 164, 223, 242). Mechanistically, the catechol ring has been shown to form a 
complex with the ferric iron when it is bound with transferrin or lactoferrin, reducing the 
iron binding affinity of these proteins (132, 164, 223, 242). This releases the iron from 
transferrin or lactoferrin, the free iron can then bind to bacterial ferric iron binding 
siderophores, such as enterobactin (223). The precise molecular details of how 
catecholamines release transferrin and lactoferrin complexed iron remains to be elucidated, 
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for bacteria such as E. coli (223, 258) or Salmonella (259). However, this does not explain 
the results observed in the present study where dopamine produced a strong enhancement 
of growth in a rich medium, where neither transferrin nor lactoferrin were added. 
Additionally, as mentioned above, the enhancement effect on bacterial growth was also 
described for DHMA and NE, which was not reproduced in our experiments. Nonetheless, 
the differences between studies may be explained by differences in media and 
concentrations of catecholamines, as previously suggested (94). Since catecholamines were 
described to bind to inorganic iron (Fe3+), we speculate that dopamine may be able to 
reduce free iron to Fe2+ by itself, which then could be taken up by bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Concluding remarks 
Approaching the microbial endocrinology field from the microbiome perspective may 
provide a better understanding of the specific mechanisms by which microorganisms can 
influence the host and vice versa. Specifically, considering chemotaxis in the context of the 
host-microbe interactions may provide a deeper understanding of the behavior of enteric 
bacteria within the host. Although the mechanism of hormone sensing by E. coli 
chemoreceptors remains to be further elucidated, we could show that spermidine is 
specifically sensed as a repellent by the low abundance receptor Trg and that this response 
is mediated by the periplasmic binding protein PotD. 
Since bacterial chemotaxis is primarily a single-cell behavior, it may be highly important for 
the survival and proliferation of enterobacteria in the GI tract (74). The apparent correlation 
found between chemotactic preferences, growth effects and the nature of the tested gut 
compounds (i.e., food-derived or secreted) suggest that bacteria are exposed to gradients 
of hormones and other host-derived compounds in the mammalian gut. Consequently, 
E. coli, and most likely other motile enteric bacteria, seem to have evolved specific tactic 
responses as a way not only to avoid harmful (or locate beneficial) levels of these 
compounds, but also to orient themselves in the gut. In this context, repellent responses 
observed at high concentrations of compounds that are secreted from the gut epithelium 
may enable bacteria to limit immediate contact with the mucus layer of the GI tract, which 
is known to contain high levels of antimicrobial proteins and immunoglobulin A (IgA) (260, 
261). Furthermore, the interplay between these repellent responses and attractant 
responses mediated by low concentrations of NE and DMHA, as observed previously (75-78, 
130) and in our work, could explain chemotactic accumulation of E. coli at a certain distance 
from the mucosal surface (262). This area might represent a specific growth niche in the 
intestine (263), where bacteria can benefit from rapidly diffusing nutrients released by the 
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epithelium without being harmed by the mucosal antimicrobials. Intestinal inflammation 
has been previously shown to lead to an enhance release of nutrients (74) and electron 
acceptors (72, 264) along with a reduced hormone secretion (265-267). This might shift the 
accumulation pattern of EHEC or Salmonella, which possess chemotaxis systems that are 
nearly identical to that of the commensal E. coli, towards the mucosal surface, possibly 
promoting proliferation of Proteobacteria and infection (268). 
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APPENDIX 
 
 
Appendix-Figure 1: FRET-based analysis of E. coli chemotaxis pathway responses. (A) Wild-type cells 
expressing CheY-YFP and CheZ-CFP were stimulated by addition and subsequent removal of attractant, 1 mM 
α-methyl-DL-aspartate (MeAsp) and addition and subsequent removal of repellent, 1 mM and 10 mM 3,4-
dihydroxymandelic acid (DHMA), at the time points indicated by arrows. Attractants inhibit the kinase activity 
of CheA, leading to a decrease in FRET, which is observed as a decrease in the YFP/CFP ratio due to the 
reduced numbers of CheY-P-CheZ complexes. Conversely, removal of attractants or stimulation by repellents 
leads to an increase in the YFP/CFP ratio. (B) Time traces of fluorescence intensity in the YFP (yellow) and CFP 
(cyan) channels for the FRET response observed in (A). Opposite changes in the two channels, characterize 
specific FRET response. 
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Appendix-Figure 2: Example of a scatter plot of RNA-seq data. As a means to study variations in the 
expression levels of genes between different experiments, we use the fold change between one experiment 
serving as a control and a second experiment. In the scatter plots, a fold change of 0 represents no changes in 
the gene expression between the two experiments and appears on the identity line in the middle of the plot. A 
fold change more than 2 can be found outside the fold lines parallel to the identity line of the scatter plot. 
Genes upregulated in comparison with the control experiment have a positive value in tables and can be 
found in the experiment’s half of the scatter plot. Consequently, genes on the other half of the plot are 
downregulated in comparison with the control experiment and have a negative value in tables. 
 
 
 
Appendix-Figure 3: Typical FRET measurements of the wild-type cells to L-3,4-dihydroxyphenylanine (L-
DOPA) (A) and serotonin and putrescine (B). Measurements were performed and plotted as in Figure 14.  
 
 
Appendix-Figure 4: Typical FRET measurements responses of wild-type cells to epinephrine (A, B). B shows 
the individual fluorescence channels changes with epinephrine. Measurements were performed and plotted 
as in Figure 14.  
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Appendix-Figure 5: Typical FRET measurements responses of wild-type cells to 1 mM of A-chain of insulin. 
Measurements were performed and plotted as in Figure 14. 
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Appendix-Figure 6: Typical Examples of FRET measurements for Tar-only cells (left side) and Tsr-only cells 
(right side). Responses to dopamine (A, B), NE (C, D), DHMA (E, F), melatonin (G, H) and spermidine (I, J) are 
shown. Measurements were performed and plotted as in Figure 14. 
 
 
Appendix-Figure 7: Typical Examples of FRET measurements for Tar-only cells (A) and Tsr-only cells (B) to 
insulin. Measurements were performed and plotted as in Figure 14. 
 
 
 
 
Appendix-Figure 8: Typical FRET measurements of responses to spermidine. Measurement examples for 
∆trg strain (A), wild-type cells (B), ∆potD strain (C) and ∆potD complemented with the plasmid pJL02 (potD+) 
(D). The absence of response to 1 mM of ribose was used as negative control demonstrating Trg receptor 
deletion (A). Cells adapted to 1 mM of ribose (indicated by the green arrows), stimulated with increasing 
concentrations of spermidine (B). Measurements were performed and plotted as in Figure 14. 
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Appendix-Figure 9: Typical examples of growth curves in presence of gut compounds. MG1655 cells were 
grown as in Figure 29, at 37°C in TB (control – red curve) and supplemented with 1 mM of dopamine, 
epinephrine, NE, L-DOPA, DHMA, melatonin, serotonin, putrescine or spermidine as indicated (grey curves). 
The optical density (OD600) was measured every hour. 
 
 
 
Appendix-Figure 10: Effects of the gut compounds on maximal OD of E. coli culture. Cells were grown as in 
Figure 29. Culture density was determined after 14 h OD600 values were plotted normalized to the control 
culture with untreated cells (red line). Error bars indicates the standard deviation. 
 
 
Appendix-Figure 11: Example of growth curves in presence of gut compounds in M9 medium (A) and SAPI 
medium (B). MG1655 cells were grown as in Figure 29 at 37°C in the respective media (control – red curve) 
and supplemented with the indicated compounds. The optical density (OD600) was measured every hour. 
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Appendix-Figure 12: Example of growth curves of deletion strains of iron transporters in E. coli in the presence 
(filled line) and absence (dashed line) of 1 mM of dopamine. MG1655 cells were grown as in Figure 29, at 37°C 
in TB media. 
 
 
Appendix-Figure 13: Analysis of qseB and qseC genes transcript abundance when dopamine and NE were 
added. qRT-PCR analysis was performed to compare the qseB and qseC gene transcript abundance between 
the control (no supplement) and 1 mM of dopamine and NE in MG1655 strain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix-Table 1: Genes with more than 1-fold changes between the control and the 
correspondent experiments: Melatonin, Dopamine and DHMA 
 Gene Control expression level 
Experiment 
expression level 
Fold change 
DH
M
A 
ybiJ 4.99791 7.3135 4.978 up 
rrsH 4.37075 6.53634 4.487 up 
rrsC 4.13163 6.15435 4.063 up 
yhak 5.61523 3.90685 3.18 up 
ydfB 2.12861 -1.18107 9.915 down 
leuP 2.5857 -0.63449 9.319 down 
rhaM 2.5857 0.30173 4.072 down 
citD 2.32763 -0.40587 4.035 down 
tauB 1.60681 -0.82306 3.609 down 
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ylcI 1.02864 0.36209 3.376 down 
yahM 2.11747 0.86594 3.268 down 
DO
PA
M
IN
E 
tdcD 7.8243 7.65679 7.084 up 
fecB 8.71909 8.35577 4.752 down 
fecA 9.44297 9.06653 5.072 down 
fecC 7.35204 6.92396 4.957 down 
fecD 7.11429 6.64099 4.872 down 
fecE 7.35982 6.84933 4.628 down 
trpE 2.87698 3.47354 4.416 down 
tyrU 1.98774 2.19154 1.151 up 
yncL -2.32697 1.22349 11.716 up 
M
EL
AT
O
N
IN
 
rrsH 4.37075 6.53634 4.486 up 
rrsC 4.13163 6.15435 4.063 up 
rrlH 4.47799 6.36015 3.686 up 
rrlA 4.54066 6.39942 3.626 up 
rrsD 3.32387 5.16936 3.593 up 
rrsA 3.36313 5.20056 3.573 up 
rrlC 4.81539 6.63114 3.52 up 
rrlD 3.35774 5.05405 3.24 up 
cadB 5.10414 5.76898 1.585 up 
dcuC 7.37603 6.80627 1.484 down 
fdnG 5.58797 6.10085 1.426 up 
narH 8.51779 8.9337 1.334 down 
tdcB 8.93905 8.53902 1.319 down 
fdnH 4.39913 4.77402 1.296 up 
narJ 6.94695 7.29189 1.27 up 
narK 9.0451 9.3864 1.266 up 
tdcC 8.8498 8.56456 1.218 down 
nikB 5.85117 6.13592 1.218 up 
narI 6.87043 7.14733 1.211 up 
nikA 5.79321 6.05035 1.195 up 
nirD 9.61348 9.3569 1.194 down 
ansB 8.57096 8.3151 1.194 down 
nirB 9.5536 9.29802 1.193 down 
narG 10.13059 10.38224 1.19 up 
dmsA 7.89024 7.64589 1.184 down 
nikC 5.77265 6.01113 1.179 up 
yjjW 6.49289 6.25604 1.178 down 
dmsB 7.65029 7.41899 1.173 down 
tdcD 7.8243 7.65679 1.123 down 
dmsC 7.47147 7.30872 1.119 down 
yecH 4.81791 4.70869 1.078 down 
 
 
nirC 7.9817 7.9121 1.049 down 
nikD 5.70084 5.76043 1.042 up 
adiY 4.99123 5.0478 1.039 up 
napA 7.48937 7.5244 1.024 up 
yhbV 5.62688 5.64595 1.013 up 
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